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        RNA aptamers are in vitro sequences of RNA that have a high affinity for their target ligand. 
They have applications in therapeutics, biosensors and molecular machines. While the practical 
applications of aptamers are increasing, it is important to study their structure and thermodynamics to 
improve the understanding of these molecular tools. The malachite green aptamer (MGA) provides a 
model system to study the interactions between aptamer and ligand that do not involve hydrogen 
bonding between ligand and receptor. While the original application of this aptamer was abandoned, 
study of the MGA binding pocket revealed an electronegative environment that was harnessed for 
catalysis. MGA binding also supported the notion that aptamers bind by adaptive binding. Adaptive 
binding is the ability of molecules to mold themselves around the structure of a ligand thereby 
incorporating it into their three-dimensional fold. 
         To further expand our understanding of MGA binding and to clarify conflicting reports of 
affinities, we conducted isothermal calorimetry binding studies. The results reveal that the entropy of 
complex formation plays a large role in determining binding affinity and ligand specificity. This data 
combined with previous structural studies show that metal ions are required to stabilize the complexes 
with non-native ligands, whereas, the complex with the original selection target is stable at low salt 
and in the absence of divalent metal ions. Next, competitive binding studies using isothermal titration 
calorimetry were conducted with the aim of understanding the adaptive nature of RNA. The results of 
these studies reveal that there are limits to the adaptability of the aptamer. Binding of one type of 
ligand reduces the affinity of the aptamer pocket to a differently shaped ligand, even if this second 
ligand has a significantly higher affinity. 
        The ability of MGA to change ligand preference based on buffer conditions, and the previously 
reported catalysis suggested that RNA may have a potential supporting multiple functions in the same 
molecule. To investigate this possibility we attempted to select an aptamer that supports both ligand 
binding and catalysis. By conducting both a DNA and RNA selection we hoped to add to the 
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collection of DNA and RNA aptamers selected for the same target. There are currently too few of 
these to determine if any correlation can be made between DNA and RNA sequences that bind the 
same target. The target of the selection was fluorescein diacetate (FDA), which was chosen with the 
aim that it would allow the exploration of the inherent potential of the selected aptamer to cleave FDA 
to fluorescein. The RNA selection proved to be more successful and an attempt was made to 
characterize the binding of the aptamer to its target fluorescein diacetate. Unfortunately there were 
complications with the binding assays, but future work is proposed that should address the issues.  
         In order to expand the MGA catalytic repertoire attempts were made to synthesize new ligands 
that could exploit the catalytic potential of the MGA binding pocket. Unfortunately these attempts 
were unsuccessful, however further attempts are recommended. The MGA used in this study was 
transcribed in vitro using T7 RNA polymerase. This process is known to add extra nucleotides to the 
end of the transcription product. Attempts were made to eliminate the n+1 product by introducing a 
ribozyme or DNAzyme. These were met with difficulties resulting in low yield, however mass 
spectrometry revealed that n and n+1 MGA bind to ligand. This, along with secondary structure 
prediction suggests that MGA n+1 behaves the same as n.   
        Overall, the results presented here provide insights into the capabilities of RNA aptamers with 
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 Ribonucleic acid (RNA) participates in many cellular processes including protein 
translation, signalling, and regulation (Bartel 2007, Beringer 2008). The first function of RNA 
identified was the transfer of information from deoxyribonucleic acid (DNA) to proteins. The 
RNA was termed messenger RNA or mRNA (Brenner, Meselson and Jacob 1961). In this 
model DNA is responsible for information storage and proteins are responsible for catalytic 
function (Crick 1958, Crick et al. 1961). The discovery that RNA was capable of catalyzing 
RNA cleavage changed the perception of RNA’s function (Guerrier-Takada et al. 1983, Cech, 
Zaug and Grabowski 1981). RNA sequences that are capable of catalytic activity are called 
ribozymes. This discovery led to the proposal of the RNA world hypothesis which suggests 
that early life went through a stage where RNA was responsible for information storage and 
catalytic function (Gilbert 1986). 
RNA involved in translation 
 The discovery of mRNA was followed by the identification of ribosomal RNA or 
rRNA (Kay 1968) and transfer RNA or tRNA (Morris and Demoss 1965). rRNA interacts 
with specific proteins to form the ribosome (Tso 1962).  The ribosome is responsible for 
translation of mRNA code to protein sequence, it achieves this through interactions with 
tRNA and mRNA (Salas et al. 1967). tRNA assists the transcription of codons by acting as a 
translator (Bock, Soll and Cherayil 1967). The ribosome brings together mRNA, based on 
complementary interaction of mRNA and tRNA codons (Harvey Lodish 2000). Then rRNA 
catalyzes a peptidyl transferase reaction to elongate amino acid chain forming proteins 
(Nissen et al. 2000). The discovery that the RNA component of the ribosome that is 
2 
 
responsible for this catalysis supports the idea of an RNA world. This function of RNA 
showed that large proteins required RNA to be synthesized and were possible after RNA 
developed this ability (Cech 2009). 
RNA involved in regulation 
 In the past 50 years more classes of RNA have been identified; these include small 
interfering RNA or siRNA (Hamilton and Baulcombe 1999), micro RNA or miRNA (Bartel 
2007), small nucleolar RNA or snoRNA (Ganot, Caizergues-Ferrer and Kiss 1997), piwi 
interacting RNA or piRNA (Grivna et al. 2006), long non-coding RNA or lncRNA (Ben 
Amor et al. 2009) and riboswitches (Winkler, Cohen-Chalamish and Breaker 2002). RNA has 
also been observed recently to function as an extracellular signalling molecule (Dinger, 
Mercer and Mattick 2008). These RNA function in conjunction with protein molecules to 
achieve gene regulation, each of the different RNA are described in more detail below. 
 siRNA and miRNA are short sequences of RNA that by Watson Crick base pairing 
form double stranded strands with target RNA. These double stranded RNA are targeted by 
cellular degradation mechanisms (Hannon and Rossi 2004). The difference between siRNA 
and miRNA lies in the role they play, siRNA are largely regarded as defense against 
exogenous RNA while miRNA is responsible for regulation of endogenous genes (Carthew 
and Sontheimer 2009). snoRNA identifies RNA for modification and guides protein to 
modification site. These modifications, including methylation and pseudouridylation, are 
important for proper folding in rRNA and tRNA (Balakin, Smith and Fournier 1996). piRNA 
are a testis specific class of RNA.  
They participate in gene silencing similar to miRNA and siRNA, and have been found to 
target sequences that are prone to relocating themselves within the genome also known as 
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transposons (Wahid et al. 2009). With the exception of mRNA the above mentioned RNA are 
non-coding RNA (ncRNA), meaning that they have function other than providing the code for 
translation.  Long ncRNA are ncRNA that are longer than 200 nucleotides. lncRNA can be 
processed to make siRNA or miRNA but are also functional as regulators in long form (Ben 
Amor et al. 2009). Riboswitches are sequences of RNA that bind to a specific small molecule, 
the binding event causes a change in structure that regulates  transcription of a neighbouring 
gene (Winkler, Nahvi and Breaker 2002).  
2. RNA in therapeutics 
 The roles RNA plays in cells make it an appealing target for molecular therapeutic and 
diagnostic applications. RNA also makes for a potential drug molecule due to the variety of 
molecules it can bind. Using systematic evolution of ligands by exponential enrichment 
(SELEX) (Ellington and Szostak 1990, Tuerk and Gold 1990) it is possible to select for an 
RNA that targets a specific molecule. RNA sequences identified by SELEX to have a high 
affinity for a target are referred to as aptamers (Ellington and Szostak 1990).  
 An overview of two approaches to utilizing the properties of RNA including targeting 
RNA with a drug and using RNA itself as a drug will be provided. This is followed by a 
review of RNA aptamer : protein/RNA interactions and RNA aptamer : small molecule 
interactions that have medical implications.  
Targeting RNA with Drugs 
 Types of RNA that have been targeted using small molecule drugs include rRNA, 
tRNA and mRNA (Thomas and Hergenrother 2008). Of the mentioned RNA targets only 
rRNA is targeted directly, the other two involve indirect effects. Targeting tRNA involves 
inhibition of aminoacyl-tRNA synthetases, which are responsible for attaching amino acids to 
4 
 
cognate tRNA (Jarvest et al. 2002). While targeting mRNA involves using naturally occurring 
riboswitch regulation by providing ligand mimics to regulate mRNA (Blount and Breaker 
2006). 
 rRNA has long been a target for antibiotic drugs (Fourmy, Recht and Puglisi 1998), 
however as more is learned about rRNA function more specific drugs are being developed. 
For example significant progress has been made in targeting rRNA to reduce the incidence of 
nonsense mutations that are associated with the Duchenne muscular dystrophy phenotype. 
There are currently multiple drugs in phase I and II clinical trials (Muntoni and Wood 2011) 
pertaining to this neuromuscular disorder. PTC124 is currently being tested in phase III trials. 
It is a small molecule which binds to the 60S ribosome and allows for selective translational 
bypass of nonsense mutations (Wilton 2007). These nonsense mutations are responsible for 
build-up of incorrectly translated protein that leads to disease conditions (Welch et al. 2007).  
RNA as a drug 
 Currently there are several aptamers in phase I and II clinical trials (Bouchard, 
Hutabarat and Thompson 2010). These include aptamers for treatment of coronary artery 
bypass (Dyke et al. 2006), macular degeneration (Ng et al. 2006) and acute myeologenous 
leukemia (Bates et al. 2009). Macugen is an aptamer based drug that targets vascular 
endothelial growth factor (VEGF) currently available for treatment of macular degeneration 
(Deissler and Lang 2008). This aptamer is conjugated to a polyethylene glycol (PEG) to 
increase its lifetime in vivo. PEG increases the lifetime of biomolecules in vivo by changing 
the biomolecules hydrophobicity and electrostatic binding properties (Veronese and Mero 
2008). PEGylation turns the main disadvantages of RNA drugs, the low lifetime due to 
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degradation, into advantage by allowing tailoring of the lifetime of the drug based on size of 
PEG (Bouchard et al. 2010). 
3. Large biomolecule RNA aptamer interactions   
 
 Many efforts have been directed at developing aptamers that target the human 
immunodeficiency virus or HIV by specifically targeting the HIV regulator of virion 
expression (Rev) peptide, trans-activation response element (TAR) HIV RNA or HIV trans 
activator of transcription (Tat) peptide (Lebars et al. 2008, Matsugami et al. 2003, Ye et al. 
1999). 
HIV Rev peptide  
 The HIV Rev peptide binds to the envelope gene, specifically to the Rev response 
element. It is responsible for transporting mRNA that encodes viral proteins to the cytoplasm 
(Zapp et al. 1991, Tiley et al. 1992, Heaphy et al. 1991). The study of the structures of HIV 
rev peptide in complex with RNA aptamers demonstrates how RNA can influence the 
structure of its ligand. Depending on the RNA sequence, the peptide binds in either an α-
helical or elongated form (Ye et al. 1999). This knowledge is important if the peptide RNA 
complex is to be targeted.  
HIV Tat 
  The HIV Tat peptide binds to  TAR HIV RNA and is necessary for transcription 
initiation, an important part of the viral life cycle (Frankel 1992). The HIV Tat aptamer 
complex was studied by using the simplest analog of Tat, an argininamide molecule 
(Matsugami et al. 2003). Argininamide was used as an analog of Tat since the peptide is an 
arginine rich peptide and an arginine was implicated in binding to the TAR region (Tao and 
Frankel 1992). This revealed the aptamer was binding two argininamide molecules suggesting 
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that it interacts with two arginine residues on the peptide (Matsugami et al. 2003). Inhibition 
of binding of Tat to TAR was observed when Tat is captured by the aptamer (Yamamoto et al. 
2000). 
TAR-HIV RNA  
 The interaction of the aptamer selected against TAR-HIV RNA reveals a kissing 
complex where non canonical inter RNA interactions along with stacking interactions create a 
stable complex (Figure 1) (Van Melckebeke et al. 2008).  These types of complexes are 
important to the viral life cycle. For example, the HIV-1 genomic RNA dimerization initiation 
site (DIS) kissing complex formed by two DIS elements triggers viral RNA dimerization 
(Paillart et al. 2004). It has been shown that the hydrogen bonding network within the kissing 
complex along with intermolecular stacking interactions is responsible for molecular 
recognition (Lebars et al. 2008).   
 
Figure 1.   TAR – TAR aptamer kissing complex; in red HIV TAR and in blue HIV TAR 
aptamer. PDB ID 2NR1 (Van Melckebeke et al. 2008). Figure was generated 




MS2 coat protein 
 Another virus that has been targeted for aptamer development is bacteriophage MS2. 
This virus has been used as a model system to study RNA-protein interactions (Stonehouse et 
al. 1996, Valegard et al. 1994). The MS2 coat protein is responsible for recognition of a stem 
loop within the genome and binding to this loop is part of a process that initiates 
encapsidation (Grahn et al. 1999).  Structural investigations of this aptamer and MS2 coat 
protein revealed the aptamer binds to protein in a similar manner to other stem loop RNA’s. 
Hydrogen bonding between protein and RNA is apparent in different stem loops as well as the 
aptamer (Horn et al. 2004). 
RNA polymerase 
 Viral RNA interactions are not the only RNA interactions of interest that have been 
addressed by aptamer development. Other targets include RNA polymerases and initiation 
factors. RNA polymerases, the enzymes responsible for transcription of DNA to RNA can be 
inhibited by binding of RNA molecules (Espinoza, Goodrich and Kugel 2007, Trotochaud 
and Wassarman 2005).  Structural work on the RNA aptamer bound to RNA polymerase II 
(Figure 2A) highlighted a possible mechanism for inhibition. The aptamer binding blocks the 
initiation center so template DNA cannot reach the catalytic center. B2 RNA is an ncRNA 
that supresses mRNA transcription by inhibiting RNA polymerase II in response to heat shock 
(Espinoza et al. 2004). Competitive binding of B2 RNA and RNA polymerase II RNA 
aptamer to RNA polymerase II was investigated. The absence of B2RNA binding revealed by 
these experiments suggests that B2 RNA may bind in the same way as the aptamer 
(Kettenberger et al. 2006). Since the RNA aptamer binds in the A-form within the RNA 
polymerase II cleft, it was also suggested that this maybe how 6S RNA (which also inhibits 
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RNA polymerase II (Trotochaud and Wassarman 2005)) binds to the RNA polymerase II, this 
cleft naturally accommodates B-form DNA templates (Kettenberger et al. 2006). 
 
Figure 2. RNA aptamer (RED and ORANGE) bound to protein (GREEN) A) RNA 
polymerase II,  PDB ID 2B63 (Kettenberger et al. 2006) B) Nf-kb homodimer, 
PDB ID 1OOA (Huang et al. 2003). Figure was generated using UCSF 
Chimera (Pettersen et al. 2004). 
Initiation factors  
 Initiation factors are proteins that bind to the ribosome during translation. The NF-kb 
factor is involved in activating genes and has been the target of therapeutic inhibition of 
cancer cells (Darnell 2002). In the case of the mammalian transcription factor binding, the 
RNA aptamer mimics DNA structure (Figure 2B). The pre-bound structure of the RNA 
resembles B-form DNA, upon binding it adapts to the presence of the protein (Reiter, Maher 
and Butcher 2008). The mammalian initiation factor 4A binding interaction with its RNA 
aptamer were studied by obtaining structures of individual RNA aptamer loops and evaluating 
the interactions with the initiation factor.  These studies suggest that binding involves the 
interaction of the aptamer’s AUCGCA loop with the initiation factor (Sakamoto et al. 2005). 
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Future structural work may reveal how these aptamers could interfere with the factors 
interacting with the ribosome. 
Prion protein 
 RNA aptamers have also been used to study protein targets whose primary function 
does not involve interaction with RNA, such as prion proteins and immunoglobulins. Prion 
proteins are infectious particles responsible for diseases like Creutzfeldt Jacob disease and  
spongiform encephalopathies (Huang et al. 1994). The RNA aptamer for bovine prion utilizes 
the electrostatic interaction between its phosphate backbone and lysine clusters, along with 
stacking interactions between its GGGG quadruplex and a tryptophan residue to achieve 
binding (Mashima et al. 2009). Prion protein has been found to bind to amyloid –β oligomers 
leading to synaptic dysfunction. This aptamer has been proposed for development as a 
therapeutic agent for Alzheimer's disease, since the prion protein plays a role in impairment of 
synaptic plasticity (Lauren et al. 2009). The prion aptamer has already been shown to reduce 
the formation of prion protein in infected cells, most likely by preventing prion protein from 
interacting with native proteins (Proske et al. 2002). 
Human immunoglobulin G 
 Human immunoglobulin G (IgG) is a protein responsible for identifying pathogens 
(Litman et al. 1993). The structure of human IgG bound to its aptamer reveals the interactions 
that make it specific for this particular immunoglobulin. These involve stacking interactions 
with Tyr373; unlike other protein RNA interactions, the binding is not driven by the 
interaction of negatively charged phosphate and positively charged surface of protein 
(Nomura et al. 2010). This is significant because it has expanded the type of ligand that can be 
considered a target for aptamer development. 
10 
 




 The antibiotics that target rRNA have been investigated further by the development of 
aptamers that bind them with high affinity and specificity. Neomycin B is an aminoglycoside 
antibiotic that inhibits a variety of RNA-mediated biological functions (Fourmy et al. 1998). 
The structure-function relationship of Neomycin B and other aminoglycosides has been 
studied with relation to the ribosome. Two binding sites have been identified, one on helix 44 
of the small ribosomal unit and the other on helix 69 of the large ribosomal subunit.  In the 
small ribosomal subunit, neomycin binds within a pocket formed by an A : A base pairing and 
an unpaired A. These residues are responsible for increasing affinity to cognate tRNA –
mRNA. When antibiotic is bound the ribosome is immobilized into high affinity configuration 
recognizing both cognate and non-cognate tRNA-mRNA complexes leading to miscoding 
(Magnet and Blanchard 2005).  In the large ribosomal subunit, it binds within a helix with 
binding stabilized by contacts including a CAAUAC loop and G1906. This helix is swung 
away from an interface of subunit association by the ribosome recycling factor (RRF). 
Binding of the antibiotic restores interactions destabilized by the RRF and inhibits ribosome 
recycling (Borovinskaya et al. 2007).  Neomycin B in complex with HIV-1 DIS (previous 
mentioned) has since been crystallized and its structure determined. This binding interaction 
is similar to that involved in the small ribosomal unit (Bernacchi et al. 2007, Freisz et al. 2008, 
Ennifar et al. 2003). These structures reveal that the mode of interaction between RNA and 
Neomycin B can vary.  The binding of Neomycin B to its aptamer has been investigated to 
obtain a better understanding of aminoglycosides RNA interactions, Figure 3 shows a few of 




Figure 3. Neomycin B bound to RNA. A) Neomycin B aptamer, PDB ID 1NEM (Jiang 
et al. 1999) B) HIV Tat, PDB ID 1QD3 (Faber et al. 2000) C) 30S ribosome 
Neomycin binding site, PDB ID 2QAN (Borovinskaya et al. 2007) D) 50S 
ribosome Neomycin B binding site, PDB ID 2QAO (Borovinskaya et al. 2007) 
E) HIV DIS complex, PDB ID 3C7R (Freisz et al. 2008). Neomycin B is 
colored PURPLE. RNA is color coded A-RED, U-CYAN, G-GREEN, C-
YELLOW. Figure was generated using UCSF Chimera (Pettersen et al. 2004).  
  
 Neomycin B binds to the aptamer within a pocket consisting of three consecutive GU 
base pairs and a flap formed by an adenine base (Jiang et al. 1999). This pocket is different 
from the aforementioned binding sites. Further investigation of this interaction determined 
that hydrogen bonding interactions between aptamer and ligand were the major mechanism 
responsible for binding (Cowan et al. 2000).  A more recent study used NMR techniques to 
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show that protonation of Neomycin B accompanies binding its cognate aptamer, 
demonstrating the ability of RNA to influence its ligand (Freire et al. 2007). The 
thermodynamic differences in binding of these complexes and other RNA complexes will be 
discussed in the following section. 
 Other antimicrobial agents have been used as targets for development of aptamers. 
These include tetracycline, tobramycin and streptomycin. Characterization of these complexes 
has clarified different aspects of RNA small molecule interactions and most of these aptamers 
have also been used to develop biosensors for medical applications (Liu, Cao and Lu 2009). 
For example the tobramycin aptamer has been incorporated as part of an aptasensor that can 
detect tobramycin and other aminoglycosides in human serum (Gonzalez-Fernandez et al. 
2011).  
Tetracycline 
 Tetracycline, tobramycin and streptomycin are antibiotics that like neomycin, target 
the bacterial ribosome. The tetracycline aptamer boasts a more complicated aptamer structure 
than usually obtained by SELEX against a small molecule. The tetracycline aptamer consists 
of three helices, creating a binding site out of tertiary contacts between the helices. ITC 
studies of the tetracycline riboswitch revealed a two-step binding mechanism driven by 
favourable enthalpy. Tetracycline’s interaction with the 30S ribosomal subunit is stabilized by 
hydrogen bonding interactions as opposed to the aptamer which has stacking interactions with 
two rings of tetracycline (Xiao, Edwards and Ferre-D'Amare 2008, Brodersen et al. 2000).  
Tobramycin and Streptomycin 
 The structures of two aptamers selected for tobramycin have been solved. Both 
aptamer tobramycin complexes revealed that the antibiotic binds within a deep groove and has 
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multiple hydrogen bonding contacts with the RNA. While both aptamers share the binding 
motif, one uses a base bulge to widen RNA major groove while the other has three mismatch 
pairs. Since both aptamers have comparable binding affinities this example reveals that 
changes to the binding site can be diverse (Jiang and Patel 1998, Jiang et al. 1997).  The 
streptomycin aptamer has also been studied by the same group that investigated the structure 
of tobramycin and neomycin aptamers. This aptamer consists of S turns that create a cavity to 
encapsulate streptomycin (Tereshko, Skripkin and Patel 2003). 
Purine 
 Naturally occurring aptamers consist mainly of riboswitches, these sequences affect 
the secondary structure upon binding its ligand to allow for transcription of the following 
sequence. Similarity between an artificially selected aptamer and naturally occurring RNA 
can be seen in purine binding RNAs. The structure of the purine riboswitch has been obtained 
and reveals that the ligand is encapsulated by the RNA. Kinetic studies of this binding 
interaction suggest that the ligand first engages in Watson-Crick base pairing with Y74 
followed by a loop closure that traps the ligand in the binding pocket and subsequent 
formation of hydrogen bonds between ligand and RNA (Gilbert et al. 2006). Furthermore 
mutation studies of the purine riboswitch reveal the ability of RNA to form bound-like 
structure through ligand mimicking. The term ligand mimicking is used to describe a receptor 
mimicking the presence of a ligand with a residue that has characteristics of the ligand. The 
mutant purine riboswitch is inactive, with one of its nucleotides (G39) occupying the active 
site (Delfosse et al. 2010). While the structure is not yet available, other biochemical methods 
suggest that an artificially selected adenine aptamer has a similar dependence on hydrogen 
bonding versus stacking interactions (Meli et al. 2002). The guanine aptamer has a consensus 
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sequence similar to tobacco ring spot virus satellite RNA hairpin ribozyme (Kiga et al. 1998). 
The part of purine riboswitch sequence that matches closest to the guanine aptamer is 
involved in binding (Figure 4). 
 
Figure 4. Comparing guanine aptamer consensus sequence to A) hairpin ribozyme B) 
purine riboswitch. Image generated using ClustalX 2.1. 
 
S-Adenosyl methionine  
 The S-Adenosyl methionine (AdoMet) riboswitch is important in the regulation of 
amino acid biosynthesis (Grundy and Henkin 1998). The structural study of the AdoMet 
bound aptamer revealed that the interaction between RNA and AdoMet primarily involves the 
adenosine of AdoMet. Investigation of the interaction of other metabolites with the AdoMet 
riboswitch has suggested possible regulatory roles (Edwards et al. 2010). The AdoMet 
riboswitch is a potential target for antimicrobials due to its regulatory role in bacteria 





5. Thermodynamic parameters 
 The binding of two molecules is generally discussed in terms of the free energy 
change (ΔG), the enthalpy change (ΔH), the entropy change (ΔS) and dissociation constant 
(Kd). The thermodynamic parameters involved in binding interactions are related to each other 
by the Gibbs Helmholz equation (Equation 1). 
    ΔG = ΔH – TΔS   (Equation 1) 
ΔG is related to the binding affinity by Equation 2, with (R) being the gas constant and (T) the 
absolute temperature. 
    ΔG = - RT ln(1/Kd)   (Equation 2) 
Kd is the dissociation constant defined and can be defined as the rate ligand enters binding 
pocket over the rate at which the ligand leaves binding pocket. It is apparent from these 
equations that binding is stronger, Kd lower, the more negative is the value of ΔG. From 
Equation 1 it can be gleaned that a negative ΔH will push the value of ΔG to a larger negative 
value. Likewise, a positive value for ΔS will push the value of ΔG to a larger negative value. 
A negative value of ΔH will be referred to as favourable ΔH and is associated with the 
increase of interactions between ligand and receptor, while a positive value of ΔH will be 
referred to as unfavourable ΔH and is associated with reducing number of interactions 
(Jelesarov and Bosshard 1999). A negative value of ΔS will be referred to as unfavourable ΔS 
and is associated with a decrease in randomness (e.g. restricting movement) while a positive 
value of ΔS will be referred to as favourable ΔS and is associated with an increase in 
randomness (e.g. release of water molecules) (Jelesarov and Bosshard 1999).  
 Table 1 shows a summary of thermodynamic data for binding of the above mentioned 
RNA targets. The general trend is that binding is driven by favourable ΔH with some 
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unfavourable ΔS. The two outliers to this trend are the purine riboswitch and the DIS HIV 
kissing loop. 
 
Table 1: Summary of RNA binding thermodynamic data 
 
Target RNA ΔH(kcal/mol) ΔS(kcal/mol/K) ΔG(kcal/mol) Kd (nM) 
Neomycin 
B(Cowan et al. 
2000) Aptamer -21.6 -0.0440 -8.488 690 
Tetracycline(Mulle
r et al. 2006) Aptamer -22.9 -0.0352 -12.428 1 
purine 
riboswitch(Gilbert 
et al. 2006) Aptamer -40.3 -0.0976 -10.730 17 
AdoMet riboswitch Aptamer -24.0 -0.0462 -10.231 32 
Tyrosinamide(Lin 
et al. 2008) DNA Aptamer -23.7 -0.0539 -7.638 2439 
Malachite(Bernard 
Da Costa and 
Dieckmann 2011) Aptamer -25.9 -0.0569 -8.790 280 
Neomycin 
B(Bernacchi et al. 
2007) DIS kissing-loop -9.4 0.0027 -10.200 34 
Neomycin B(Kaul 
and Pilch 2002) Ribosomal A site -16.2 -0.0279 -7.900 1550 
 
 The purine riboswitch has a higher amount of favourable enthalpy change while DIS 
HIV kissing loop has a lower ΔH. It is interesting to note that in both cases the variation of 
favourable ΔH is compensated by the inverse adjustment in unfavourable ΔS. The DIS HIV 
binding has a 20% greater amount of ΔG from charge related interactions than the small 
ribosomal binding site (Bernacchi et al. 2007). While the purine riboswitch has a significant 
amount of hydrogen bonding (Gilbert et al. 2006) which might explain the ΔH differences. 
These two examples suggest that artificially selected aptamer binding follows a different trend 
compared to the naturally occurring RNA small molecule interactions. However examining 
the AdoMet riboswitch the thermodynamic parameters are almost identical to the aptamers. 
This suggests that there is still too small a set of data to make generalizations about the 
thermodynamic trends.  The similarity in energetics of binding is eclipsed by the specificity of 
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each binding pocket created by differences in sequence and geometry of the binding pocket 
(Appendix Table A1).  
6. Conclusions 
 
 A common trend seen with the aptamers selected for larger biomolecules is that they 
mimic the type of interactions that already exist in organisms. This is seen clearly in the 
aptamer for TAR HIV RNA, which forms a kissing complex similar to that seen in HIV DIS 
(Van Melckebeke et al. 2008, Paillart et al. 2004). This phenomenon is implied by the work 
with RNA polymerase II aptamer and B2RNA competitive binding to RNA polymerase II 
(Kettenberger et al. 2006).  
 In the case of aptamers for antibiotics, the naturally occurring RNA that binds to the 
same targets has clear differences in their binding pockets.  This is a reflection of the 
evolution of RNA, since the naturally occurring RNA did not have a selection pressure driven 
purely by affinity to target, but rather by their function within the system (cell/virus). As seen 
in the case of tobramycin with two aptamers that use different means to widen the binding 
pocket (Jiang and Patel 1998, Jiang et al. 1997) and multiple ATP aptamers (Huang and 
Szostak 2003) it is possible to have variations of sequences that have strong binding affinity 
and nature has had multiple variations to explore other functions.  
 The closer relatives to artificially selected aptamers, riboswitches, do at least in the 
case of adenine, share similarity. Another example of similarity in sequence between 
artificially selected aptamer and naturally occurring RNA is that of the ATP aptamer binding 
motif which was found in a bacterial virus (Shu and Guo 2003). The aptamers that select for 
small molecules do provide a window into the capacity for function that RNA has, and the 
roles it could have played in a prebiotic world.  
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 The number of aptamers is increasing as methods to select them become more routine, 
even including in silico techniques (Chushak and Stone 2009). 2'-Locked RNA aptamers are 
aptamers where there is a 2'O, 4'-C methylene link which confers RNA C3' endo 
conformation. This change results in an entropic constraint that leads to increased affinity for 
target (Schmidt et al. 2004). This, along with other developments in degradation resistant 
nucleotides (Minakawa et al. 2008) promises many applications for aptamers to come. 
 RNA binding usually involves adaptive interactions and this has been seen for binding 
to peptides and small molecules (Patel et al. 1997, Ye et al. 1999, Flinders et al. 2004). This 
makes it important to probe the conformational mobility and thermodynamics of binding so 
that the aptamer target molecule interaction is characterized. This line of investigation can be 
supplemented by site-directed modification of the aptamer to change the spatial configuration 
or the energy of the binding interaction. For example the binding affinity of tRNAGln to 
glutaminyl-tRNA synthetase was improved by studying the related aptamer, the 
improvements did not involve the RNA protein contacts but instead were driven by tertiary 
structure stabilization of the RNA (Lee and McClain 2004). Another important reason for the 
study of structure and thermodynamics of RNA-ligand interactions is to understand the nature 
of RNA-induced modifications of the ligand itself. A good example of such behaviour is seen 
in the conformational changes induced by malachite green molecules binding to cognate 
aptamer, and these changes are significant enough to change the optical properties of the dye 
molecule (Nguyen et al. 2004). This type of binding interaction could expand modalities of 
drug interactions, such as aptamer-assisted pro-drug delivery.  
 Understanding the nature of the interactions between target and drug molecule has 
improved the rational design of protein targeting molecules (Noble, Endicott and Johnson 
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2004). The structure-function paradigm is being applied to rational design of biologically 
active therapeutic RNA. This effort is assisted by the use of aptamer models to understand 
nature of RNA-molecule interactions.  
7. Research Outline  
 The following chapters describe our studies of RNA ligand interactions in binding and 
catalysis. This involves the malachite green aptamer (MGA) which was selected to bind 
malachite green dye (MG) (Baugh, Grate and Wilson 2000). MG or 4-[(4-
dimethylaminophenyl)-phenyl-methyl]-N,N-dimethylaniline has been used in aquaculture 
industry to treat fish and fish eggs due to its antiseptic, antibacterial and antifungal properties 
(Hall and Unestam 1980, Alderman 1985). MG has been found to inhibit enzymes including 
acetylcholinesterase (Kucukkilinc and Ozer 2008) and multidrug-binding repressor protein 
QacR (Peters et al. 2011).  
 An introduction to MGA and the thermodynamic studies done with MGA binding, to 
MG and derivatives, is covered in chapter 2. This chapter was published under the title 
“Entropy and MG
2+
 control ligand affinity and specificity in the malachite green binding 
RNA aptamer” in Molecular BioSystems (Appendix Note A1). The introduction has been 
expanded and the rest of the paper has been reproduced with permission from RCS publishing 
(Appendix Note A2). These experiments pointed to a significant difference in the binding of 
the different derivatives. To further explore the nature of binding pocket, competition binding 
studies were conducted and are discussed in chapter 3. Chapter 3 has been submitted for 
publication under the title “Not so adaptive binding: Ligand competition in an RNA aptamer” 
and is currently under review. In addition to material submitted for publication chapter 3 
contains preliminary computational work. The multiple capabilities revealed by our binding 
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studies and previously discovered catalytic capacity (discussed in chapter 2) stimulated the 
attempt to select a new aptamer and determine if this varied capacity would be replicated. 
This selection is discussed in chapter 4 along with a brief comparison of DNA and RNA 
aptamers for the same target. Finally a report of the attempts to purify MGA of uniform 




Chapter 2: Structure and Thermodynamics in the Malachite Green RNA Aptamer 
1. Introduction 
  Aptamers have been developed for a wide variety of targets and are excellent 
model systems for RNA-ligand interactions (Chapter 1). The mode of binding in different 
aptamers varies greatly depending on their targets and selection procedure. For example, 
the Neomycin B RNA aptamer binding is driven largely by hydrogen bonding (Cowan et 
al. 2000) while the malachite green RNA aptamer (MGA) binding is driven by 
electrostatic and stacking interactions (Flinders et al. 2004). MGA has been utilized as a 
bioprobe in combination with microtubules (Hirabayashi et al. 2006), as a fluorescent 
sensor (Xu and Lu 2010, Zhang et al. 2009), an assay for malachite green (MG) (Stead et 
al. 2010), as part of a diagnostic molecular automata (Hirabayashi, Ohashi and Kubo 
2010) and for the validation of molecular docking software (Detering and Varani 2004).  
  MGA was originally engineered for binding specificity to the tri-phenyl dye 
malachite green (Grate and Wilson 1999) The secondary structure of MGA and chemical 
structure of MG are shown in Figure 1 A and B, respectively. The purpose behind 
selecting this aptamer was to harness MG’s destructive potential. MG has been found to 
generate hydroxyl radical from water when irradiated with red laser light and these 
radicals damage surrounding biomolecules (Liao, Roider and Jay 1994). The design 
involved appending MGA into the non coding region of a target gene. MG is then 
introduced and binds to MGA. Subsequent irradiation of target region leads to formation 
of radicals which damage the mRNA and damaged mRNA would be degraded by the cell 
(Grate and Wilson 1999). The discovery of siRNA which can target mRNA sequences for 
degradation (Hamilton and Baulcombe 1999) without the need to introduce a carcinogenic 
dye made such a method obsolete. However MGA proved useful in exploring the potential 
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of aptamers in molecular biology, the insertion of this sequence in S.cerevisiae resulted in 
cell cycle regulation by MG. MGA was capable of doing this without the use of laser 
irradiation. The structural changes upon binding MG were sufficient to prevent the 40S 
ribosomal subunit to interact with cyclin gene transcripts (Grate and Wilson 2001).  
  The structure of the aptamer bound to ligand was initially solved by X-ray 
crystallography in complex with the MG derivative tetramethylrosamine (TMR) (Figure 
2) (Baugh, Grate and Wilson 2000) and later by NMR spectroscopy in complex with the 
original selection target MG (Flinders et al. 2004) (Figure 1C). The binding pocket of the 
MGA (Figure 1A) consists of a base quadruple (C7:G24:A31:G29) and a Watson-Crick 
base pair (G8:C28) which serve as stacking platforms for malachite green (MG, Figure 
1B). In addition, the nucleotides A9 and A30 are positioned in such a way that they almost 
completely close the pocket on one side (Figure 1C) (Flinders et al. 2004, Baugh et al. 
2000). The other residues in the internal loop region of the aptamer act as linkers and 
anchors, for the nucleotides that are in contact with the ligand. 
  The major difference between the structures of the MGA-TMR and the MGA-MG 
complexes is that in order to accommodate the non-planar MG, the aptamer undergoes a 
small rearrangement that can be best described as a rotation of the upper part of the 
binding pocket relative to the lower part (Flinders et al. 2004). This provides enough 
space to accommodate the rings of MG in the binding pocket, but also leads to a loss of 
some stacking interactions. Both structures reveal a lack of hydrogen bonding between 
MGA and ligand, this provides an excellent model system to study the role of electrostatic 





Figure 1.  (A) Schematic of the MGA complex used in these studies. Nucleotides that 
form the top and bottom of the binding pocket are shown in orange and 
blue, respectively. (B) Structure of malachite green (MG). (C) Space filling 
model of the MGA binding pocket from the solution structure (1Q8N). The 
ligand is shown as ball and stick model. Same colour scheme as in (A). 
Graphics prepared with UCSF Chimera (Pettersen et al. 2004). 
  The study of the MGA-ligand interactions have shown that ligands can undergo 
significant changes in their electronic structure and charge distribution when bound inside 
an RNA binding pocket (Nguyen et al. 2002). The MG molecule responds to the unique 
electrostatic environment inside the RNA aptamer with a redistribution of its positive 
charge as well as a conformational change (Nguyen et al. 2004). These observations 
suggested that the environment inside the RNA binding pocket can have a significant 
effect on the chemical properties of the bound ligand. Further studies revealed that the 
malachite green aptamer can indeed act as a ribozyme when presented with a suitable 
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substrate molecule. An acetyl-ester derivative of malachite green undergoes an accelerated 
hydrolysis reaction when bound to the aptamer (Brackett and Dieckmann 2006), this 
reaction is discussed further in chapter 5. 
The abovementioned studies and applications of the MGA and other aptamers indicate 
the need for a generalized understanding of ligand–RNA interactions as basis for further 
developments. Isothermal titration calorimetry (ITC) has been established as a standard 
method for the detailed study of the thermodynamics of RNA–small molecule and RNA–
protein interactions (Chapter 1) as well as RNA folding processes (Feig 2007).  Insights into 
the thermodynamic forces that drive ligand binding and dissociation open a way for a better 
understanding of these important interactions that are the basis for drug action and catalysis. 
We have conducted ITC studies investigating the binding of MGA to MG under a variety of 
solution conditions. In addition to binding of MGA to MG, MGA binding to MG derivatives 
was investigated. MG derivatives tested included tetramethylrosamine (TMR), pyronin Y 
(PY), and crystal violet (CV).  Figure 2 shows the structure of these derivatives. PY has a 
planar structure similar to TMR, but lacks the third ring, while crystal violet (CV) has a non-
planar structure similar to MG, with an extra dimethylamine group on ring C. 
 
Figure 2. Chemical structure of MG derivatives used in this study: A) Crystal violet 




Initial binding experiments 
The primary method to determine thermodynamic parameters of MGA binding to 
ligands was ITC studies. Initially two other methods were attempted to determine binding 
constants, equilibrium dialysis and fluorescence intensity titrations. These along with NMR 
studies provided the motivation to investigate the binding of MGA to derivatives.  
 In the course of NMR studies of MGA in complex with MG, TMR and PY it became  
apparent that the complexes with TMR and PY were not as stable as the corresponding MG 
complex under the NMR conditions (low salt, no divalent metal ions). This appeared to be a 
contradiction with the affinities reported in the original study (Baugh et al. 2000) where both 
TMR and PY formed more stable complexes with MGA than the original ligand MG. The Kd 
values for MG, TMR and PY were reported as 800 nM, 40 nM, and 225 nM, respectively. 
These values were determined at low salt but in the presence of divalent metal ions (10 mM 
K-cacodylate pH 5.8, 10 mM MgCl2, 10 mM KCl). In our NMR studies, divalent metal ions 
were avoided to ensure sample stability during data acquisition and low salt was necessary to 




Figure 3.  Comparison of 2D NOESY spectra of A) MGA-MG and B) MGA-TMR 
complexes in 100% D2O at 293K. The spectra were acquired on a Bruker 
DRX 600 MHz spectrometer in 10 mM potassium phosphate buffer, pH 6.0 
and 10 mM KCl. 
Figure 3 shows a comparison of 2D NOESY spectra of 1:1 mixtures of MGA:MG and 
MGA:TMR. It is clearly apparent that the TMR spectrum shows much broader and fewer 
cross-peaks than the corresponding MG spectrum, indicating a less dynamic complex (faster 
exchange between free and bound RNA or multiple conformations). In order to address these 
apparent contradictions, preliminary equilibrium dialysis experiments were conducted to 
determine binding affinities under conditions closer to those used in the NMR studies (100 
mM phosphate buffer, 50 mM KCl, pH 6.0).  
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Equilibrium dialysis was conducted using DispoEquilibrium DIALYZER (Havard 
Apparatus, Massachusetts, USA). The DIALZYER consists of two chambers connected by a 
semipermeable membrane. MG and derivatives can pass through membrane, while MGA due 
to larger size can not. MGA is added to one chamber and due to the membrane is trapped 
there. MG or derivative is added to the other chamber and allowed to equilibrate. Binding of 
MG or derivative to MGA, shifts equilibrium of free ligand, causing more to move into MGA 
chamber.  
These experiments showed that PY had a significantly lower affinity (8.35±3.7 µM) 
than MG (0.26±0.08 µM) under these conditions (Figure B1 in Appendix). These initial 
results prompted us to thoroughly investigate the binding behaviour of MGA in complex with 
its ligands using fluorescence based titration studies. 
Fluorescence titration studies relied on the change in fluorescence properties of the 
ligands when bound to MGA (Baugh et al. 2000). The fluorescence binding experiments were 
conducted using a Nanodrop fluorometer to test all four dyes whose affinities had been 
previously reported. This method was chosen since it required minimal amounts of RNA and 
closely resembled the methodology used in the original study. The binding affinity was 
determined by using the change in fluorescence as concentration of MGA was increased while 
ligand concentration was kept constant in 50 mM phosphate buffer, 150 mM NaCl, pH 6.7.  
The dissociation constants for the MGA complexes formed with MG, TMR, CV and 
PY were found to be 2.73±0.6 µM , 0.8±0.2 µM , 7.6±1.7 µM  and 7.6±1.1 µM , respectively 
(see Figure B2 in Appendix). These results confirm the trend seen in the equilibrium dialysis 
study, but do not explain the low stability of the TMR complex seen in the NMR studies. 
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Surprisingly, CV, which was thought to not interact with the aptamer, seems to have a binding 
affinity similar to PY, but PY shows a much weaker binding than seen in the original study 
(Baugh et al. 2000). Overall these results indicated that a more comprehensive analysis of the 
binding behaviour of MGA with these ligands under a broad range of salt conditions was 
needed in order to understand binding specificity and affinity.  
Isothermal titration calorimetry experiments 
ITC is based on monitoring the enthalpy involved in a reaction that occurs as a ligand 
is gradually added to a reaction cell containing receptor. The instrument monitors the 
temperature and the energy required to maintain the temperature of the reaction cell. It also 
determines the energy required to maintain the temperature of a reference cell. This energy is 
subtracted from the energy required to maintain the temperature of the reaction cell, the 
difference corresponds to the energy involved in the reaction (Wiseman et al. 1989, Ladbury 
2004).  The analysis of this data provides ΔH, ΔS, ΔG and Kd as reported by Wiseman et al.  
ITC studies were conducted at three different salt concentrations (1 mM, 150 mM, 1.0 
M NaCl) and in the presence of the divalent metal ion (10 mM MgCl2). Thermodynamic 
parameters for the four ligands obtained from these experiments are summarized in Table 1. 
Overall, the affinity of the ligands increased with salt concentration. The binding of CV at 1 
mM salt was below detection threshold and the high salt value could not be determined 
because CV precipitated at 1 M salt. The presence of MgCl2 at low salt concentrations in 
general increases affinity, reaching almost a third of the Kd at 150 mM NaCl for MG and 
TMR, and half the Kd at 150 mM for PY. The only exception is CV where the change in 
affinity in the presence of Mg
2+
 is not significant. MGA has comparable affinity for TMR and 
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MG, with TMR binding slightly tighter at higher salt concentrations and in the presence of 
Mg
2+
. On the other hand, MG has a higher affinity at low salt in the absence of Mg
2+
. Both 
TMR and MG bind significantly tighter than PY and CV which have similar affinities at 150 
mM salt, with PY improving in the presence of magnesium. For all four ligands increasing 
salt concentration or the addition of Mg
2+
 leads to tighter binding. The lower Kd values are 
predominantly caused by more favourable entropy terms. The exception is PY for which the 
entropy term does not change significantly in the presence of higher salt or divalent ions. 
Table 1.  ITC determined thermodynamic parameters for MG, TMR, PY and CV at 
various salt concentrations, pH 6.7 at 25
o
C. 
Dye Salt Concentration Kd(M)
a ΔH(kcal/mol)
a ΔS(cal/mol/deg)a ΔG(kcal/mol)a 
MG 1 mM NaCl 0.80±0.06 -29.23±1.69 -70.13±5.83 -8.33±0.06 
 150 mM NaCl 0.28±0.07 -25.93±2.24 -56.87±7.92 -8.98±0.14 
 1 M NaCl 0.37±0.06 -25.76±2.64 -56.93±8.54 -8.79±0.10 
 1 mM NaCl 10 mM MgCl2 0.10±0.01 -23.10±1.35 -45.37±4.42 -9.58±0.04 
      
TMR 1 mM NaCl 1.06±0.08 -25.23±2.94 -57.27±10.01 -8.16±0.05 
 150 mM NaCl 0.28±0.04 -18.32±1.09 -31.43±3.55 -8.95±0.08 
 1 M NaCl 0.14±0.05 -13.46±0.44 -13.63±1.07 -9.39±0.18 
 1 mM NaCl 10 mM MgCl2 0.08±0.02 -17.29±1.51 -25.50±5.26 -9.69±0.12 
      
PY 1 mM NaCl 14.28±5.04 -13.36±2.22 -22.53±7.94 -6.64±0.20 
 150 mM NaCl 4.08±0.20 -17.81±0.38 -35.03±1.20 -7.37±0.03 
 1 M NaCl 2.65±0.42 -15.34±1.03 -25.93±3.71 -7.61±0.09 
 1 mM NaCl 10 mM MgCl2 1.65±0.67 -16.94±1.77 -30.20±6.52 -7.94±0.23 
      
CV 150 mM NaCl 4.45±0.08 -78.27±14.60 -280.0±49.15 -7.35±0.09 
 1 mM NaCl 10 mM MgCl2 3.79±0.12 -54.48±9.71 -158.0±32.60 -7.40±0.01 
 
a Average of three independent measurements each. Curves were fit to a single binding site model. For a typical ITC isotherm see Figure B3 in Appendix. 
3. Discussion 
Entropy Driven Binding 
The thermodynamic characteristics of the interactions between MGA and four 
different derivatives of MG were measured under four different buffer conditions by 
isothermal titration calorimetry. The binding affinity of MGA for each dye is predominantly 
controlled by the entropy of binding (Figure 4). CV is the most flexible of the four ligands 
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and also has the most even distribution of partial charge prior to binding. Hence it suffers the 
largest entropy penalty upon binding when it is forced into a restricted conformation and 
localized charge distribution that is dictated by the RNA binding pocket. At 150 mM 
monovalent salt concentration TMR and PY have similar binding entropy values, whereas 
MG binding is accompanied by a larger entropy penalty. This can be rationalized because in 
TMR and PY rings A and B are planar due to the bridging oxygen atoms. On the other hand, 
the MG molecule is more flexible in its free form with rings A and B able to rotate 
independent of each other and hence it shows a larger entropy penalty upon binding. 
 
Figure 4. Relationship between entropy of complex formation and salt concentration for 
dye derivatives binding to MGA. 
This behavior is similar to that observed for intercalation binding of small molecule 
ligands to DNA. Intercalators show a thermodynamic signature with a large favourable 
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enthalpy contribution originating predominantly from stacking interactions which is countered 
by a near zero or unfavourable entropy component. The latter is caused by the need to 
reorganize the structures of nucleic acid and ligand into more rigid or entropically less 
favourable conformations (Chaires 2008). The observation of this kind of thermodynamic 
signature makes sense for the MGA complexes because ligand binding and recognition in 
these molecules does not involve any hydrogen bonding interactions between RNA and 
ligand, relying exclusively on stacking as well as electrostatic interactions (Baugh et al. 2000, 
Flinders et al. 2004). 
Metal ions control specificity 
Interestingly, the entropy penalty for PY binding does not significantly decrease at 
higher salt concentrations or in the presence of Mg
2+
 as seen for the binding of MG and most 
clearly for TMR. PY differs from TMR and MG by the lack of the third phenyl ring (Ring C). 
Hence it seems that the changes in binding entropy at low and high salt can be largely 
attributed to interactions between the MGA and ring C of the ligand. An examination of the 
crystal structure of the MGA-TMR complex (Baugh et al. 2000) and the NMR structure of the 
MGA-MG complex (Flinders et al. 2004) shows that A30 which is stacked against ring C of 
the ligand is part of a bulge/loop structure consisting of A30, A31, U32 and G33. Previous 
mutation studies have shown that this structure element is important for binding of MG and 
TMR (Flinders et al. 2004). Interestingly, in the crystal structure a Sr
2+
 ion is positioned in 
such way, that it can interact with the phosphate oxygen atoms of A30, A31 and G33. This 
suggests that the presence of divalent ions (Mg
2+
) or a sufficiently high concentration of 
monovalent ions (KCl or NaCl) is needed to stabilize this element of the binding pocket and 
thereby the interaction with the ligand. This becomes especially noticeable when ligands other 
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than the original selection target (MG) are bound. The preference for a divalent metal ion is 
not surprising considering the presence of Mg
2+
 during the original selection procedure (10 
mM MgCl2) (Grate and Wilson 1999).  
The influence of magnesium on binding affinities is interesting because it shows that 
the ligand specificity of the MGA is controlled by the solution conditions. While the aptamer 
has a lower affinity for all the ligands at low salt concentrations (Figure 5), the binding 
affinity of MGA for MG is higher than its affinity for TMR at low salt. This is the reverse of 
what is seen at high salt concentrations where TMR has higher affinity. 
 
Figure 5. Relationship between salt concentration and affinity for MG and TMR binding 
to MGA as determined by ITC. 
Even though the effect is small, this change in ligand preference is significant in an 
aptamer selected solely for binding to one target (MG). The ability of MGA to change its 
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ligand preference depending on the solution conditions demonstrates the large influence of 
environmental factors on RNA selection/evolution and also highlights the adaptability of 
RNA. 
Comparison to Previously Reported Affinities  
The binding affinities reported here differ from some of the values previously reported 
in the literature (Baugh et al. 2000, Babendure, Adams and Tsien 2003, Flinders et al. 2004, 
Wang et al. 2009).  The affinity for TMR (Kd = 0.08±0.02 µM ) is similar to that originally 
reported by Baugh et al. (Kd = 0.04 µM ) (Baugh et al. 2000). These affinities were 
determined under comparable buffer conditions. Baugh et al. used fluorescence intensity or 
anisotropy to follow titrations of MGA with TMR and PY.  They also reported the binding 
affinity for MG and CV. These values were determined by competitive inhibition of TMR 
binding. The affinity of MG reported by Baugh et al. (Kd = 0.80 µM ) is lower than our value 
(Kd = 0.10 µM ), which is similar to that determined by Babendure et al. (Kd = 0.117 µM ) 
(Babendure et al. 2003). The latter value was determined by following the fluorescence 
intensity of MG during a titration. This discrepancy is likely due to the use of a pre-bound 
MGA-TMR complex. With a preformed binding pocket that is matched to the planar TMR 
molecule, the binding of MG is kinetically unfavourable and the reported Kd value might not 
be determined at equilibrium. It should be noted that the affinity for MG was also determined 
by Wang et al. (Wang et al. 2009) using fluorescence intensity. However, their studies were 
carried out at a higher pH and lower MgCl2 concentration (Kd = 1.03±0.53 µM). The concept 
of a preformed binding pocket reducing affinity for other ligands is supported by the low 
affinity for CV (Kd > 1 mM) as reported by Baugh et al.. The conformation of CV deviates 
significantly from that of TMR and thus it would have difficulty to replace TMR in a 
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preformed complex. This would explain the large difference to our value (Kd = 3.79±0.12 µM 
) which was determined for CV binding to an unoccupied RNA pocket. One puzzling 
observation is that the affinity for PY reported by Baugh et al. (Kd = 0.225 µM ) is 
significantly higher than the value found in our ITC (Kd = 1.65±0.67 µM ) and fluorescence 
intensity-based studies (Kd = 7.6 µM , no Mg
2+
) under comparable buffer concentrations. This 
difference could potentially be a result of intercalation/unspecific binding of PY in addition to 
the regular binding inside the MGA pocket. PY is known to bind to nucleic acids via 
intercalation in double stranded regions with a preference for RNA (Darzynkiewicz et al. 
1986, Kapuscinski and Darzynkiewicz 1987). However, under the conditions used in our 
studies we do not see any evidence of significant intercalation for PY or any of the other dyes. 
Electrostatic contributions 
For aptamers where the binding affinity was studied as a function of salt 
concentration, the common trend is in general a decrease in affinity and an increase in entropy 
penalty as salt concentration increases (Cowan et al. 2000, Hossain and Kumar 2009, Islam 
and Kumar 2009, Stampfl et al. 2007).
 
This observation is typically rationalized by the 
decrease in polyelectrostatic interactions or a destabilization of bound complex and can be 
utilized to reveal the effect of hydrogen bonds which are unaffected by the salt concentration. 
Since the MGA complexes lack hydrogen bonding interactions between ligand and RNA, it 
was expected that the affinity would decrease as salt concentration increases. However the 
effect we see is an increase in affinity with increasing salt concentration. As discussed above, 
this effect is most likely due to a structural stabilization of the binding pocket by metal ions. 
Wyman (Wyman 1964) and Tanford (Tanford 1969) have proposed the following equation 





]   (Equation 1) 
Z is the apparent charge on the bound ligand, and ф is the fraction of Na
+
 bound per nucleic 
acid phosphate.  –Zф can be obtained from the slope of a log Ka versus log [Na
+
] plot 
(Mascotti and Lohman 1990, Record, Lohman and Dehaseth 1976). 
 log Ka/ log [Na
+
] = -Zф  (Equation 2) 
These equations have previously been used to analyze the thermodynamic properties of the 
Neomycin (Cowan et al. 2000) and L-tyrosinamide aptamers (Lin et al. 2008). In both these 
cases the Zф value was a positive one since the slope from equation (2) was negative. Using 
this positive value of Zф in equation (1) results in a negative value for ΔGelec, since log[Na
+
] 
is a negative value for concentrations below 1 M.  For the MGA complexes in our study, the 
slope of log Ka vs. log [Na
+
] is positive (see Figure B4 in Appendix) and thus results in a 
positive value for ΔGelec. This suggests that the electrostatic contribution from ion release is 
not favourably assisting complex formation in the case of MGA. It is important to note that 
equations (1) and (2) were intended to account for the polyelectrostatic effect which suggests 
that a large part of nucleic acid binding interactions involves the entropy from the 
displacement of Na
+
 ions. In the case of MGA this effect is probably masked by the structural 
stabilization outlined above. 
Enthalpy-Entropy Compensation 
Enthalpy-entropy compensation is seen for the binding of the different ligands to 
MGA as a function of salt concentration. This phenomenon has been observed for a variety of 
biomolecules (Cooper et al. 2001). The slope of a line generated by plotting entropy vs. 
enthalpy at different salt concentrations for the different ligands produces a linear correlation 
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with the equation ΔS= mΔH + b. The compensation effect seen for MGA-MG binding (Figure 
6), has a similar slope (m = 3.19) as seen in other aptamers, for example the Neomycin RNA 
aptamer and the L-tyrosinamide aptamer (m = 3.27 when plotting the ΔH vs. ΔS values from 
these studies) (Lin et al. 2008, Cowan et al. 2000). Interestingly, this slope is also similar to 
that reported for several proteins (m = 3.33) (Cooper et al. 2001). These similarities may be 
an effect of entropy and enthalpy reaching equilibrium. 
 
Figure. 6 Enthalpy-Entropy compensation with increasing salt concentration for several 
RNA aptamer–ligand complexes. MG,TMR and PY in complex with MGA . 
Neomycin and L-tyrosinamide in complex with their respective aptamer. The 
line represents a linear fit of all data points and has a slope of 3.19. 
4. Conclusions 
The results of the binding studies presented here illustrate the adaptability of RNA 
aptamers. This was seen when the aptamer was presented with derivatives or close relatives of 
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the original selection target. This property of small RNAs would be a significant advantage 
when it comes to responding to a changing environment and selection pressure in a pre-biotic 
setting. The functional adaptability would have allowed early RNA sequence pools to quickly 
diverge and expand their abilities during the establishment phase of an “RNA world” (Joyce 
and Orgel 1993).  
The comparison of the results from our study and the previous studies discussed above 
also illustrates the necessity for taking solution conditions into account when comparing 
structures and binding properties for RNA aptamers. Even though the original in vitro 
selection utilized magnesium ions as buffer component, the NMR study of the MGA-MG 
complex (Flinders et al. 2004) did not reveal any beneficial effect of adding Mg
2+
 ions to the 
solution. In fact, the rapid degradation of the samples in the presence of magnesium and the 
difficulty of obtaining monomeric RNA hairpins at higher salt led to the use of a low salt 
buffer for the structure determination. On the other hand, the MGA-TMR complex yielded 
very poor quality NMR spectra under these conditions which were puzzling at the time 
because of the high affinity of TMR that was seen in binding studies. The necessity of high 
salt or Mg
2+
 for the formation of a stable MGA-TMR complex that is revealed by the ITC 
study explains these observations.  
The results of the ITC binding studies illustrate the importance of the third ring for 
MGA binding. MG and TMR both have a high affinity with different entropy values due to 
the differences in planarity and rigidity. PY which is planar but lacks the third ring shows an 
affinity similar to CV which has the third ring but is non-planar. This suggests a crucial 
interaction between the third ring of the ligand and MGA. The solvent conditions affect the 
affinity and specificity of MGA for the different dyes. At low salt, MGA has the highest 
38 
 
affinity for MG, while at high salt MGA has highest affinity for TMR. This is consistent with 
the crystal structure of the TMR-MGA complex which shows a possible binding site for a 
divalent metal (Baugh et al. 2000). These observations suggest that the optimal structure for 
MGA to bind MG versus TMR might be different, with MGA bound to TMR structure 
requiring added stability provided by divalent ion. To investigate this phenomena further 
competition binding experiments were undertaken discussed in the following chapter. 
5. Materials and Methods  
Ligand Preparation 
Malachite green was purchased from Sigma Aldrich (Sigma-Aldrich Corporation, 
Milwaukee, U.S.A). Tetramethylrosamine was purchased from Invitrogen (Invitrogen 
Corporation, California, U.S.A). Pyronin Y was purchased from Acros Organics (Acros 
Organics, Geel, Belgium). Crystal Violet was purchased from Fisher Scientific (Fisher 
Scientific Company, Ottawa, Ontario, Canada). Dyes were dissolved in water to make 20 mM 
stock solutions. Dilutions for different buffer conditions were prepared from these stocks. 
 Synthesis of RNA 
The MG aptamer used for ITC was prepared enzymatically from a synthetic DNA 
template by using T7 RNA polymerase and unlabeled NTPs (Milligan et al. 1987, Milligan 
and Uhlenbeck 1989), as described previously (Flinders et al. 2004). After transcription, the 
pyrophosphate was removed by centrifugation and the RNA was collected by precipitation 
with ethanol. The RNA was then separated from NTPs and aborted products on a 12% PAGE. 
The resulting RNA band was then run on a HiPrep 16/10 DEAE FF anion-exchange column, 
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followed by desalting on a Hiprep 26/10 Desalting column and lyophilization to dryness. All 
columns used for RNA preparation were purchased from GE Healthcare, Uppsala, Sweden.  
Isothermal titration calorimetry studies 
Experiments were performed at 25 
o
C on a MicroCal ITC 200 microcalorimeter 
(MicroCal, Inc., Northampton, Massachusetts, U.S.A). The 10-15 μM RNA solution was 
prepared by dissolving lyophilized RNA in pH 6.7 10 mM sodium phosphate buffer at desired 
salt concentration. The 100-150 μM dye solutions were prepared by dissolving solid dye in 
pH 6.7 10 mM sodium phosphate buffer at desired salt concentration. The ITC cell was filled 
with RNA solution and was titrated with dye solution from the syringe. Each experiment 
consisted of 16 injections of 2.54 µl every 300 s, with a first injection of 0.5 µl to a final 
molar ratio of 2:1 dye:RNA. In order to account for heat of dilution of dye solution, a blank 
run with buffer in cell and dye in syringe was run and subtracted from the experimental run. 
All data sets were analyzed using the Origin software package provided by MicroCal and 
fitted to a one set of sites binding model that assumes a single set of equivalent binding sites. 
NMR Spectroscopy 
NMR experiments were conducted and analyzed by Dr. Thorsten Dieckmann. All spectra were 
collected on a Bruker DRX-600 spectrometer equipped with a HCN triple resonance, triple-
axis PFG probe. Quadrature detection for the indirect dimensions in multidimensional 
experiments was achieved using the States-TPPI method (Marion et al. 1989). The two-
dimensional NOESY spectra (Kumar, Ernst and Wüthrich 1980) in 100% D2O were acquired 
at 293 K with a mixing time of 250 ms. All NMR samples were in standard 5 mm NMR tubes 
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with final RNA concentrations of 0.8 to 1.8 mM in 10 mM potassium phosphate buffer, pH 
6.0 and 10 mM KCl and a 10% excess of ligand 
Fluorescence Binding Studies 
MGA solutions were prepared at concentrations between 0.2 and 13 µM. To each 
solution dye was added to get a final concentration of 1 µM. The series had a final buffer 
concentration of 50 mM phosphate buffer, 150 mM NaCl at pH 6.7. The sample fluorescence 
was measured on a NanoDrop 3300 fluorometer (Thermo Fisher Scientific Company, Ottawa, 
Ontario, Canada). For MG and CV, there was no detectable fluorescence in the absence of 
RNA. The emission maxima were 656 nm and 646 nm, respectively, when bound to the 
aptamer. The fluorescence increase was measured at 656 nm for MG and 646 nm for CV. For 
TMR and PY significant fluorescence was detected in the absence of RNA, therefore a ratio 
of bound fluorescence and unbound fluorescence was used. TMR bound fluorescence was 
measured at 584 nm and unbound was measured at 576 nm. PY bound fluorescence was 
measured at 576 nm and unbound was measured at 566 nm. The resulting curves were fitted 
to the equation y = (Bmax*x)/(Kd+x) using Origin 8.0 (OriginLab Corporation, Northampton, 
U.S.A). 
Equilibrium dialysis experiments 
Equilibrium dialysis was conducted using Dispo Equilibrium Dialyzer tubes (Harvard 
Apparatus, Massachusetts, U.S.A). Both dye and RNA were dissolved in a 100 mM 
phosphate buffer, 50 mM KCl, pH 6.7 buffer. The tubes were prepared with MGA (5 µM) in 
the receptor chamber and a range of dye concentration (5 µM -20 µM) were added to the 
ligand chamber. After 32 hours of equilibration in the dark at room temperature with gentle 
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agitation, a 50 µl sample was taken from each chamber and added to 450 µl acetic acid. 
Absorbance was measured at 546 nm on a Cary 4000 UV/Visible Spectrometer (Agilent 
Technologies). The binding curves were fitted to the equation y = (Bmax*x)/(Kd+x) using 









Chapter 3: Further exploration of the malachite green RNA aptamer binding pocket 
1. Introduction 
Competition or displacement binding isothermal titration calorimetry (ITC) studies 
involve studying the interaction of a ligand “A” titrated into a receptor that is occupied by a 
ligand “B”. This method has multiple applications including determining if both ligands have 
the same binding mode, characterizing a high affinity binding ligand and observing 
conformation flexibility.   
The model used to fit competitive binding ITC data has been previously reported for 
multiple injections (Wang 1995, Sigurskjold 2000). The report for continuous injection was 
verified using simulated data and binding of cytidine monophosphate to RNaseA (Markova 
and Hallen 2004). The continuous injection method has several advantages over multiple 
injections. The chief benefit is the time involved in the experiments, continuous injections 
require significantly less time.  The increase in speed of experiment does not decrease the 
amount of points collected along the isotherm curve, this method allows for more points along 
the isotherm curve.  
The competition binding ITC has been used for studying interleukin receptor binding 
(Lupardus, Birnbaum and Garcia 2010), as well as other receptor ligand interactions. In these 
cases a low affinity ligand is first bound to lower the affinity of a high affinity ligand to a 
measurable affinity. The conformation flexibility and binding mode of different ligands to 
cytochrome p450 has been investigated using competition binding. This along with NMR 
studies concluded that using the same residues cytochrome p450 creates two distinct binding 
niches depending on the ligand (Muralidhara, Negi and Halpert 2007).  
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Competitive binding ITC was selected in order to further explore the changes that 
MGA undergoes when accommodating different ligands inside a free or occupied binding 
pocket. The previous chapter summarized the investigation of the binding of MG derivatives 
to MGA. These derivatives included pyronin Y (PY), crystal violet (CV) and 
tetramethylrosamine (TMR). Figure 1 shows the chemical structures of related dyes that bind 
to MGA. Pyronin Y (PY) has a planar structure similar to TMR, but lacks the third ring, while 
crystal violet (CV) has a non-planar structure similar to MG, with an extra dimethylamine 
group on ring C. 
 
Figure 1. Chemical structures of dyes that bind to MGA A) MG (rings are labeled A,B,C) B) 
CV C) TMR D) PY.  
 Initial binding studies illustrated that the MGA binding pocket has the ability to adapt 
to recognize these related molecules (Baugh, Grate and Wilson 2000). This is consistent with 
the concept of adaptive binding. MG and TMR have higher affinities to MGA than CV and 
PY under all tested conditions. A comparison of our recent isothermal titration calorimetry 
studies (Bernard Da Costa and Dieckmann 2011) with the earlier binding studies by Baugh et 
al. that used a competition binding assay (Baugh et al. 2000) indicated that there might be 
differences in the way the free RNA and an aptamer with an already occupied binding site 
interact with a potential ligand.  The work done in the previous chapter showed that MGA 
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changes its preference from the original ligand MG to TMR in the presence of Mg
2+
. This 
observation emphasizes the environment dependent character of RNA-ligand interactions. 
Two structures of MGA have been determined to date; a crystal structure of the 
aptamer bound to tetramethylrosamine (TMR) (Baugh et al. 2000) and a solution NMR 
structure of the complex with MG (Flinders et al. 2004). The MGA binding pocket consists of 
a base quadruple (C7, G24, G29, A31) and a Watson-Crick base pair (G8, C28) with two base 
triples (C10, G23, A27 and U11, A22, A26) and a U turn motif providing the supporting 
frame work.  A comparison of the two MGA structures in complex with MG and TMR 
(Figure 2) shows that the most significant difference lies in the stacking patterns of the RNA 
bases at the top and bottom of the pocket. The G8:C28 base pair and the upper part of the 
pocket are rotated in the MG complex relative to their position the TMR complex. This leads 
to an un-stacking of G8 and ring A of the ligand thereby making room for the non-planar 
structure of MG. Another important element of the binding pockets is A30 which stacks with 
ring C of the ligand. A30 is part of a bulge/loop structure consisting of A30, A31, U32 and 
G33. In the crystal structure a Sr
2+
 ion is positioned to interact with the phosphate oxygen 





Figure 2. A) Secondary structure schematic of MGA with MG shown as green triangle. B) 
Superposition of the MGA NMR structure with bound MG (Green, PDB ID 1Q8N) 
and the MGA crystal structure with bound TMR (Purple, PDB ID 1F1T). The purple 
spheres indicate the position of Sr
2+
 ions in crystal structure. C) Detail view of the 
binding pocket of the superimposed structures; top : back view, bottom : front view. 
Figure was generated using UCSF Chimera (Pettersen et al. 2004). 
We have conducted competition binding experiments where PY or CV were pre-
bound to MGA (MGAPY and MGACV) while MG or TMR were titrated in.  These experiments 
illustrate how the aptamer adapts to a ligand when the binding pocket is already occupied by 
another small molecule 
2. Results and Discussion 
Characterization of free RNA by NMR spectroscopy 
 One of the key principles of adaptive binding in RNA aptamers is the absence of 
structure in the ligand- free RNA binding pocket. In order to establish if the MGA follows this 
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principle, we analyzed the amount of structure present in the aptamer RNA in absence of the 
ligand by high resolution NMR spectroscopy (Figure 3). Both the original aptamer sequence 
designed by Grate et al. and a modified version that was used for the NMR studies with an 
unsymmetrical stem and a UUCG tetraloop instead of the GAAA loop were prepared and 
analyzed by homonuclear NMR spectroscopy. Both sequences behaved identically. In the 
absence of ligand, the spectra acquired in H2O indicate that the first 6 base pairs in stem 1 and 
the stem-loop starting at G12:C21 are formed and contain stable base pairs. This is confirmed 
by the observation of sequential NOE patterns typical for A-form RNA and the 
UUCG/GNRA hairpin loops in NOESY spectra acquired in D2O and H2O. The signals 
originating from nucleotides in the internal loop/ligand binding site are heavily overlapped 
and show very few NOEs. All visible NOEs between aromatic protons originate from 
nucleotides in the two stem regions. The signal dispersion and the amount of NOEs observed 
increases drastically after addition of either malachite green or tetramethylrosamine ligand 
(Figure 3 C and D).  
The analysis of the NOE data indicates that the aptamer does not have a preferred 
structure for most nucleotides in the internal loop in the absence of MG or TMR. However, 
there is evidence for the formation of the G29:C7 base pair at the top of stem 1. Stacking 
NOEs between the C6:G33 base pair and a purine residue that is base paired to a cytidine 
nucleotide suggest that this base pair, which becomes part of the base quadruple formed by 
C7, G29, G24 and A31, is already preformed in the ligand free RNA. The structures of the 
MGA-MG and MGA-TMR complexes (Figure 2) show that the binding pocket adopts a 
somewhat different structure when binding MG (a non-planar ligand) versus TMR (a ligand 
with planar rings A + B). Since part of the base quadruple is pre-formed in the free form and 
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stabilized in the bound form as well as by the presence of divalent metal ions, we decided to 
investigate the effect of pre-binding one ligand within the pocket. The determination of the 
affinity of a second ligand that displaces the pre-bound one should provide insights into the 
effect of the structural re-arrangement that is necessary to accommodate the new ligand on the 
binding affinity. 
 
Figure 3. 2D D2O NOESY Spectra of MGA at 293K (mixing time 250 ms).  A) Aromatic to 
aromatic region of free MGA B) Ribose region of free MGA.  Red lines trace H1’ to 
base proton NOEs in the lower stem.  Blue lines trace H1’ to base NOEs in the upper 
stem, while dashed blue lines trace the connectivity through the UUCG tetraloop C) 
Aromatic to aromatic region of MGA with malachite green bound.  D) Ribose region 
of MGA with malachite green bound. 
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Competitive isothermal titration calorimetry experiments  
ITC studies were conducted at two different buffer conditions, 150 mM NaCl and 1 
mM NaCl, 10 mM MgCl2. These conditions are based on our previous ITC binding studies 
with free MGA.
17
 The competition experiments were performed with PY and CV pre-bound 
to the aptamer since pre-bound TMR and MG did not show any detectable signal when the 
competing ligand was titrated in (Figure C1 in Appendix). This is expected since MG and 
TMR had significantly higher binding affinities than CV and PY. 
Table 1.   ITC determined thermodynamic parameters for MG and TMR binding to MGAPY or 
MGACV complexes at different salt concentrations, pH 6.7 at 25 °C.  
Salt Concentration Pre-bound Titrant Kd(M)
a ΔH(kcal/mol) a ΔS(cal/mol/K) a ΔG(kcal/mol) a 
 - CV 4.45±0.08 -78.27±14.6 -280.0±49.1 -7.35±0.09 
 - PY 4.08±0.20 -17.81±0.38 -35.03±1.20 -7.37±0.03 
150 mM NaCl 
- MG 0.28±0.06 -25.93±2.24 -56.87±8.54 -8.98±0.14 
CV MG 0.10±0.01 -91.63±0.43 -276.04±1.53 -9.37±0.07 
PY MG 0.50±0.16 -37.09±0.71 -95.45±1.61 -8.65±0.23 
- TMR 0.28±0.04 -18.32±1.09 -31.43±3.55 -8.95±0.08 
CV TMR n/a n/a n/a n/a 
PY TMR 0.32±0.07 -21.80±0.46 -43.44±1.94 -8.86±0.12 
 - CV 3.79±0.12 -54.48±9.71 -158.0±32.6 -7.40±0.01 
 - PY 1.65±0.67 -16.94±1.77 -30.20±6.52 -7.94±0.23 
1 mM NaCl, 10  mM MgCl2 
- MG 0.10±0.01 -23.10±1.35 -45.37±4.42 -9.58±0.04 
CV MG 0.13±0.02 -60.56±0.53 -171.7±1.79 -9.40±0.09 
PY MG 0.21±0.06 -28.79±1.84 -66.02±6.72 -9.11±0.16 
- TMR 0.08±0.02 -17.29±1.51 -25.50±5.26 -9.69±0.12 
CV TMR n/a n/a n/a n/a 
PY TMR 0.27±0.07 -19.55±1.66 -34.57±5.81 -9.25±0.26 
a Average of three independent measurements each 
Table 1 summarizes the data obtained from the competition experiments. Table 1 also 
includes results from previous chapter for convenient comparison. CV can readily be replaced 
in MGACV by MG with a Kd of 0.1 µM, while TMR did not show any observable binding to 
the MGACV complex despite the fact that its affinity for free MGA is 16 times higher than that 
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of CV. PY is replaced in MGAPY in the by TMR easier (Kd 0.3 µM) than MG. Binding to 
MGAPY complex is reduced compared to the free RNA and involves a smaller favourable 
enthalpy change compared to that involved in binding to MGACV. The smaller favourable 
enthalpy change when MG replaces PY vs. CV suggests that this complex does not easily 
rearrange the structure of the binding site to an optimal MG binding pocket. These results 
illustrate that the binding pocket formed by adaptive binding to the pre-bound ligand is quite 
stable once formed and the rearrangement to accommodate a ligand with somewhat different 
shape is not instantaneous. This could be compared to a beanbag chair which after adapting to 
the shape of one occupant will need some time to recover its ability to optimally fit itself to 
the shape of a new occupant. The aptamer shows a degree of structure memory once it has 
adapted to a particular shape of ligand and hence there is an energy penalty when a ligand 
with a different shape attempts to displace the pre-bound ligand. This explains why MG has a 
lower affinity for MGAPY complex than for MGACV and TMR has a lower affinity for 
MGACV than for MGAPY. MG binding to MGACV complex has a large favourable enthalpy 
due to an optimized, pre-shaped binding pocket. It should be noted that some of the enthalpy 
and entropy detected could be due to the solvation of CV or PY as it exits binding pocket, 
since both CV and PY have different solubility than MG or TMR. 
Table 2.   Ratio of binding values obtained directly over binding values from competition 
experiment 




CV MG 2.80 0.28 0.21 0.96 
CV TMR n/a n/a n/a n/a 
PY MG 0.56 0.70 0.60 1.04 





CV MG 0.77 0.38 0.26 1.02 
CV TMR n/a n/a n/a n/a 
PY MG 0.48 0.80 0.69 1.05 




In order to illustrate the differences between combinations of complex formation, we 
have calculated the ratios of the thermodynamic parameters for MG or TMR binding to free 
MGA (Bernard Da Costa and Dieckmann 2011) , over the values for MG or TMR binding to 
MGApre (Table 2). For Kd a ratio above one means that the ligand has higher affinity for 
MGApre while below one indicates that the ligand has higher affinity for free MGA. For ΔH a 
ratio above one indicates the ligand has larger favourable enthalpy change for interactions 
with MGA while a value below one means that the ligand has larger favourable enthalpy 
change when binding to MGApre. For ΔS a ratio above one means ligand has a larger 
unfavourable entropy contribution when binding to MGA, while values below one indicate 
that the ligand has larger unfavourable entropy contributions when binding to MGApre. 
Interestingly, the ratio for ΔG is close to one in all cases; displaying an example of entropy-
enthalpy compensation
29
. This phenomenon suggests that biomolecules work within a limited 
free energy window, where favourable enthalpy interactions are balanced by the necessary 
unfavourable entropy needed to make interactions 
TMR binding to MGAPY has values close to those for binding to free MGA (ratio is 
close to one) at 150 mM NaCl. However, in the presence of 10 mM Mg
2+
 TMR binding to 
MGAPY is slightly reduced. This suggests that the stabilization of the pocket provided by 
Mg
2+
 reduces the ability of the aptamer to accommodate TMR. 
MG binding to MGACV has a significantly higher affinity compared to binding to free 
MGA at 150 mM NaCl. This is accompanied by a large increase in favourable enthalpy 
change and unfavourable entropy change. However, in the presence of 10 mM Mg
2+
 the 
binding affinity is similar to binding affinity to free MGA with a comparable enthalpy change 
and a slight increase in unfavourable entropy. The increase in unfavourable entropy in this 
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case is consistent between the two conditions suggesting it may have more to do with the 
solvation of CV than the binding event. The increase in binding affinity seen at 150 mM NaCl 
suggests that MG can interact more efficiently with a pre-formed binding pocket if the 
previous ligand had a similar shape as in the case of CV. In the presence of Mg
2+
, which 
stabilizes the internal loop region that includes the binding pocket, the RNA loses some of its 
plasticity and hence the ability of MG to replace CV is reduced. This observation agrees with 
our previous report that MGA changes its ligand preference from MG to TMR in the presence 
of 10 mM Mg
2+
. 
MG binding to MGAPY shows a decrease in affinity under both buffer conditions 
compared to binding to MGA (0.56 and 0.48). The favourable enthalpy at both buffer 
conditions was comparable to MGA binding but there is an increase in unfavourable entropy 
(0.60 and 0.69). Taken together with the lower binding affinity this suggests that MGAPY has 
a pocket that doesn’t allow optimal interactions as seen in MG binding MGACV. 
Computational Investigation 
Computational methods have been used to probe conformation flexibility in 
biomolecules along with other methods (Muralidhara et al. 2007).  These simulations provide 
insight into the subtle changes in conformation that accompany binding. An unpublished 
communication from Dr. Charles Wilson used molecular dynamic simulation to supplement 
kinetic studies revealing that the interactions that unraveled at 500K in simulation were the 
same interactions that were least formed in folding transition state ensemble. These residues 
whose interactions with ligand were least formed were identified as A30, A9 and G24. The 
simulation was conducted with potassium ions and using AMBER. Based on our results that 
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reveal the importance of the role of Mg
2+
, we have attempted to repeat the simulations using 
magnesium ions.  
The NMR structure of MGA was used in the simulations since it represents the 
solution structure of the aptamer. The derivatives were placed in MGA and the solution was 
heated to 500K. The complexes were then equilibrated at 500K. Equilibration was determined 
to be complete when the potential energy of the system plateaued (Figure C2 in Appendix). 
Examining the equilibrated structures shows that the distortion of the binding pocket is 
correlated with the binding affinity to ligand. MGACV has the most distorted binding pocket 
followed by MGAPY, while MGATMR and MGAMG have the least distortion from reported 
binding pocket (Figure 4). Computational experiments have to be continued to yield more 
insights into the unfolding process as the ligand leaves binding pocket, these experiments are 
discussed in the following section. 
 
Figure 4. MGA NMR structure equilibrated at 500K complexed with A) CV B) MG C) 




3. Conclusions and Future Work  
In summary, the ITC experiments described here show that MGA maintains a certain 
level of structural memory of the initial target it binds, even when challenged with a 
competing ligand that has a higher affinity for the free RNA than the pre-bound one. The 
plasticity of the free RNA aptamer allows it to adapt to somewhat differently shaped ligands, 
planar and non-planar tri-phenyl dye derivatives in this case. However, once the RNA has 
adopted the optimal fold for a specific shape of ligand it maintains this fold at least partially 
for some time after the ligand leaves the pocket. This results in an energy penalty for binding 
a differently shaped ligand, because the pocket needs to be partially unfolded in order to 
accommodate the new binding partner. 
This effect is most likely due to the ligand bound structure of the RNA representing an 
energy minimum in the RNA folding pathway. Hence the molecule becomes kinetically 
trapped in the adopted conformation and requires additional energy and time to return to an 
unfolded state that can readily adapt to a different ligand. Fully characterizing this behaviour 
is critical for understanding the way in which small molecules interact with RNA aptamers, 
for example in biosensors where initial binding of a lower affinity ligand can potentially 
prevent detection of a high affinity target or in drug development where interactions between 
different potential ligands can reduce the efficiency of an RNA targeting drug in vivo. 
The results presented here also explain the apparent contradiction between the binding 
affinities for MG (Kd = 800 nM at 10 mM Mg
2+
) and CV (Kd > 1mM at 10 mM Mg
2+
) 
reported (Baugh et al. 2000) and our recent ITC studies (Kd = 100 nM for MG and 3.8 μM for 




(Bernard Da Costa and Dieckmann 2011). The earlier affinities were 
determined indirectly by measuring changes in TMR fluorescence anisotropy in competition 
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experiments. The data presented here shows that a planar ligand like TMR cannot easily 
replace a non-planar ligand like CV during the time-frame of a typical binding experiment 
(approximately fifteen minutes for the ITC studies) and thus the Kd values determined from 
the competitive fluorescence studies significantly underestimate the affinity of MG and CV. 
This possibility needs to be taken into account when designing experiments that characterize 
RNA aptamer –ligand interactions. 
Further ITC experiments will be conducted to examine the presence of a specific Mg
2+
 
binding site. This will be done by having MGA in a buffer without Mg
2+
 placed in the cell and 
titrating Mg
2+
 into cell. This experiment will help confirm the role of Mg
2+
 suggested by our 
recent work.  Further computational experiments will involve cooling down complexes 
currently at 500 K down to 300 K. This annealing process should allow for MGA to adapt to 
its ligand. After the complexes are equilibrated at 300K it will be used for two separate 
experiments. The first experiment will involve removal of the ligand and equilibration of the 
empty MGA to observe how the pocket adjusts after ligand is removed. The second 
experiment will involve the slow extraction of the ligand and determination of the energy 
involved in extracting the ligand. This energy can be used to determine the affinity of the 
ligand for the complex (Lee and Olson 2006, Villa, Wohnert and Stock 2009). The affinity 
determined will then be compared to the affinities we have previously determined by ITC. 
This approach will also allow for the examination of the unfolding process more closely as the 





4. Materials and Methods 
RNA preparation  
The RNA used for ITC and NMR spectroscopy was prepared enzymatically from a 
synthetic DNA template by using T7 RNA polymerase and unlabeled NTPs (Milligan et al. 
1987, Milligan and Uhlenbeck 1989). After transcription magnesium pyrophosphate was 
removed by centrifugation and the RNA was collected by precipitation with ethanol. The 
RNA was then separated from NTPs and aborted transcription products by PAGE using a 
12% gel. The RNA product was then extracted from the gel by electro-elution and run on a 
HiPrep 16/10 DEAE FF anion-exchange column (GE Healthcare, Uppsala, Sweden), followed 
by salt removal on a Hiprep 26/10 Desalting column (GE Healthcare, Uppsala, Sweden) and 
lyophilization to dryness. 
 NMR samples for studying exchangeable protons were prepared by dissolving the 
lyophilized RNA in a 90% H2O / 10% D2O solution.  Samples used for studying non-
exchangeable protons were prepared by dissolving the RNA in 99.996% D2O (Cambridge 
Isotopes, Andover, Massachusetts, U.S.A).  All NMR samples were 500 μL in standard 5 mm 
NMR tubes with final RNA concentrations of 0.8 to 1.8 mM in 10 mM KCl and 10 mM 
potassium phosphate buffer, pH 5.8. 
ITC studies 
Experiments were performed at 25 °C on a MicroCal ITC 200 microcalorimeter 
(MicroCal, Inc., Northampton, Massachusetts, U.S.A). The 10–15 μM RNA solution was 
prepared by dissolving lyophilized RNA in 10 mM sodium phosphate buffer, pH 6.7 at the 
desired salt concentration. The 100–150 μM dye solutions were prepared by dissolving solid 
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dye in 10 mM sodium phosphate buffer, pH 6.7 at the desired salt concentration. RNA and 
dye for the preparation of pre-bound samples (MGACV or MGAPY) were mixed in a 1:2 ratio. 
The ITC cell was filled with the pre-bound RNA solution and titrated with the second ligand 
(MG or TMR) solution from the syringe. Each experiment consisted of a single injection over 
396 sec at a continuous flow of 0.1 μL/s to a final molar ligand /RNA ratio of 1.5. In order to 
account for heat of dilution of dye solution, a blank run with the pre-bound dye buffered in 
cell and second dye in syringe was run and subtracted from the experimental run. The validity 
of the data obtained by continuous injection was verified by comparing the data obtained via 
the standard multiple injection method with a corresponding continuous injection set (Table 
C1 in Appendix). No significant differences for binding constants or thermodynamic 
parameters were found. All data sets were analyzed using the Origin software package 
provided by MicroCal and fitted to a competitive binding model. 
NMR experiments 
NMR experiments were conducted and analyzed by Dr. Thorsten Dieckmann. All 
spectra were collected on a Bruker DRX-600 spectrometer equipped with a HCN triple 
resonance, triple-axis PFG probe.  Solvent suppression for samples in 90% H2O / 10% D2O 
was achieved using 11-spin echo pulse sequences (Sklenar and Bax 1987) or WATERGATE 
(Piotto, Saudek and Sklenar 1992). Quadrature detection for the indirect dimensions in 
multidimensional experiments was 2D CITY-TOCSY (Briand and Ernst 1991) with a mixing-
time of 50 ms, a DQF-COSY (Piantini, Sørensen and Ernst 1982), and NOESY spectra with 
mixing times of 250, 200, and 50 ms in 100% D2O were measured at 293 K. The spectra were 





 Computational experiments were conducted with the guidance of Dr. Pierre-Nicholas 
Roy, using a method similar to that used by Jason Tao to explore MG derivatives in MGA, 
these included MGOAc, MGOH and MGO. This involved inserting the derivative into the 
NMR structure of MGA using xleap. Mg
2+
 ions were added using xleap before solvating the 
complex in a 30Ǻ rectangular water box. The system was then minimized using 1000 steps 
with the solute held fixed, followed by a 10 ps MD at 300 K while placing 25 kcal/mol Ǻ 
restraints on all solute atoms and counter ions. Then the restraints were reduced gradually to 0 
kcal/mol Ǻ. The system was then annealed by increasing temperature gradually (10 K per 10 
ps) to 500 K. The system was then equilibrated at 500 K for 30 ps. Computation were all 
performed using AMBER either on sharcnet.ca or roycluster.uwaterloo.ca. 
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Chapter 4: Selection of a Fluorescein Binding Aptamer 
1. Introduction 
 The word aptamer is derived from the latin aptus meaning to fit and mer the unit used 
to measure the length of nucleotides (Ellington and Szostak 1990). Naturally occurring 
riboswitches have been identified as aptamers (Winkler, Cohen-Chalamish and Breaker 2002). 
However, many aptamers, including the first biomolecule to be identified as an aptamer 
(Ellington and Szostak 1990),  have been artificially selected through a method known as 
Systematic Evolution of Ligands by Exponential Enrichment (SELEX) (Ellington and Szostak 
1990, Tuerk and Gold 1990, Proske et al. 2005).  
SELEX 
 Briefly, this involves starting with a pool of random sequences, applying a selection 
pressure (usually a column with a ligand bound), enriching the pool by polymerase chain 
reaction (PCR) of the nucleic acid sequences that survive the first round of selection pressure. 
This is followed by repeating the process on the new pool (Figure 1). This is repeated until the 
pool converges to a few unique sequences that have a high affinity for the target. This 
technique has been used to select aptamers for a wide variety of targets from small molecules 
to whole cells (Barbas et al. 2010, Shi, Hoffman and Lis 1999, Holeman et al. 1998).  
 The use of the SELEX method has itself evolved and may include multiple selection 
pressures and negative selection pressures (Stoltenburg, Reinemann and Strehlitz 2007). The 
selection pressure step has expanded from simple columns to include magnetic beads (Nutiu 
and Li 2005), capillary electrophoresis (Mendonsa and Bowser 2004), flow cytometry (Blank 
et al. 2001), surface plasmon resonance (Misono and Kumar 2005), and in silico methods 
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(Chushak and Stone 2009). There are currently two aptamer databases that are attempting to 
amalgamate all the data available to increase the understanding of the SELEX process 
(http://aptamer.icmb.utexas.edu/ and http://aptamer.freebase.com/).  
 
 
Figure 1 Schematic of SELEX procedure. Red arrows indicate DNA SELEX. Green 
arrows indicate RNA SELEX. 
 RNA versus DNA Aptamer 
 Both DNA and RNA aptamers show robust binding affinities for various targets 
(Neves et al. 2010, Baugh, Grate and Wilson 2000, Dieckmann et al. 1995). There are two 
key differences in the building blocks of DNA and RNA. Firstly, as the name suggests RNA 
has a ribose sugar moiety while DNA has a deoxyribose, in which the 2’ OH is absent (Figure 
2a). Secondly, DNA uses thymine as a pyrimidine base instead of uracil (Figure 2b).  The lack 
of the 2’ OH gives DNA greater stability, while in RNA this group can participate in a self 
cleavage reaction. The lack of the 2’ OH also leads to a difference in preferred sugar 
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puckering which affects the overall structure DNA forms. 
 
 
Figure 2. Chemical structure representations of A) Deoxyribose and Ribose B) Thymine 
and Uracil. 
 The effect of these differences can be seen in DNA and RNA aptamers that bind the 
same ligand. These ligands include lysozyme (Potty et al. 2011), thrombin (Long et al. 2008), 
human immunodeficiency virus trans-acting responsive element (HIV TAR) (Darfeuille et al. 
2006), hemin (Liu et al. 2009a), interferon γ (Min et al. 2008), vascular endothelial growth 
factor (VEGF) (Ng et al. 2006), and dopamine (Walsh and DeRosa 2009). In the case of 
lysozyme, HIV TAR, VEGF and dopamine, the selected DNA aptamer is the analog of the 
RNA selected aptamer. The lysozyme DNA aptamer has a lower affinity than the RNA 
aptamer but is less sensitive to salt concentration. The lysozyme RNA aptamer Kd increases 
270 fold when concentration of NaCl in buffer is increased by 20 mM, while the DNA 
aptamer Kd only increases 2 fold. This suggests that electrostatic contribution is significant in 
the lysozyme RNA aptamer (Potty et al. 2011). Regardless of its lower affinity, the lysozyme 
DNA aptamer has been used as an electrochemical sensor (Li et al. 2010) and for the 
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voltammetric detection (Cheng, Ge and Yu 2007) of lysozyme. The HIV TAR RNA aptamer 
forms a kissing complex such as the one mentioned in Chapter 1. The DNA analog has a 
similar affinity to the RNA aptamer and competes for binding with Tat (Darfeuille et al. 2006). 
The VEGF RNA aptamer has been developed into the first therapeutic aptamer with a binding 
affinity in the picomolar range (Ng et al. 2006). The DNA analog VEGF aptamer has a 
binding affinity in the nanomolar range (Potty et al. 2009). Interestingly, both the RNA and 
DNA dopamine binding aptamers have similar affinity and mutation studies point to the same 
binding site (Walsh and DeRosa 2009).  
 
Figure 3. Overlap of thrombin bound DNA aptamer (RED aptamer; PINK thrombin; 
PDB ID 1HUT ) and RNA aptamer (GREEN aptamer; BLUE thrombin; PDB 
ID 3DD2 ). (Long et al. 2008) (Nimjee et al. 2009). Figure was generated 
using UCSF Chimera (Pettersen et al. 2004). 
 The hemin, thrombin, and interferon γ, DNA and RNA aptamers were selected 
through two independent selections. Both hemin aptamers have similar peroxidase activity 
though the DNA aptamer (Kd = 27 nM ) (Liu et al. 2009a) has a higher affinity than the RNA 
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aptamer (Kd 0.8 µM) (Liu et al. 2009b). The presence of peroxidase activity in both cases 
supports the idea that RNA and DNA are capable of catalysis given the right ligand. The 
crystal structures of both DNA and RNA aptamers bound to thrombin have been solved. 
These reveal that the thrombin RNA and DNA aptamers bind at different sites and have 
different binding interactions (Figure 3) (Long et al. 2008, Nimjee et al. 2009). While no 
crystal structure is available for the interferon γ aptamers, based on their sequences it is safe 
to conclude that they have different binding modes. The interferon γ RNA aptamer sequence 
(Kubik et al. 1997) is 
5’GGAGGACGAUGCGGACACCGUUAAUCUGAGGCCCUGUCCUAUUCCUUCACGCCUCAGA3’ while the 
DNA aptamer sequence (Balasubrananian et al. 1998) is 5’GGGGTTGGT TGTGTTGGGTGTTGTGT3’. 
An electrochemical detection of interferon-γ with these aptamers by Ban C. et al. showed that 
the RNA aptamer had an order of magnitude lower detection limit than the DNA aptamer 
(Min et al. 2008). Briefly, this involved attaching aptamer to a gold electrode and monitoring 
the charge transfer resistance. This value is correlated with the amount of ligand interaction 
with the electrode surface, which is related to affinity to the aptamer. 
  The difference in sequence and binding seen from selections of RNA and DNA 
aptamers compared to using analogs of a selected aptamer suggest that more data is required 
to fully understand the correlation between RNA and DNA sequence structure-function 
relationship. This was the rationale for trying both an RNA and DNA aptamer selection.  
Fluorescein as target  
 The aptamer target was selected in order to provide the possibility for practical 
applications. One of the practical applications of aptamers, as mentioned in Chapter 1, is as 
63 
 
signalling molecules. Detection methods for monitoring signals include electrochemical (Min 
et al. 2008), colorimetric (Stojanovic and Landry 2002), piezoelectric (Bini et al. 2007), and 
fluorescence (Stojanovic and Kolpashchikov 2004). Two examples of the ways to use 
fluorescence as detection method include the use of the malachite green RNA (MGA) aptamer 
chimeric probe for the detection of adenosine and the binary MGA aptamer for the detection 
of target nucleotide sequences. In the chimeric probe, the MGA is appended to an adenosine 
aptamer. The addition of a bridge sequence complementary to a part of MGA and part of the 
adenosine aptamer keeps secondary structure of MGA from folding and binding MG. The 
presence of adenosine causes the interaction with the bridge sequence to weaken and allows 
MGA to fold and bind MG, produces a detectable signal (Figure 4a) (Xu and Lu 2010). In the 
binary probe, MGA is split in two with each half attached to part of the target sequence. 
Binding to the target sequence brings the two halves together which allows for the binding of 
MG which produces a detectable signal (Figure 4b) (Kolpashchikov 2005).  
 Fluorescein has a significantly higher quantum yield of fluorescence than MG. MG 
has very little fluorescence when free and increases when bound making it useful as sensor in 
conjunction with MGA. Fluorescein is fluorescent when free in solution, while fluorescence is 
quenched by guanosine when bound to a DNA aptamer (Unruh et al. 2005). The acetylated 
fluorescein molecule has virtually no fluorescence (Figure 5). We have conducted a selection 
for an aptamer targeted at fluorescein diacetate (FDA) to add to the repertoire of signalling 
molecules and further explore RNAs capacity for catalysis. The application here would be to 




Figure 4  Schematic of different uses of the MGA. A) MGA (green line) attached to 
adenosine aptamer (red line) with the bridge sequence (purple line); adenosine 
(red pentagon) is added then MG (green triangle) is bound and fluorescence is 
produced. B) Part of target sequence (blue line) attached to half of MGA 
(green line), both target sequences binding to target brings the MGA halves 
together to allow for MG binding and fluorescence produced.  
 





 The DNA selection was conducted using magnetic beads, a method developed by Li Y. 
et al. (Nutiu and Li 2005). The initial method ( Method I, Figure 6a) was attempted by having 
the pool of DNA bind to the beads and introducing FDA. The DNA pool consisted of a bridge 
sequence flanked by random regions. The complement to bridge sequence was synthesized 
with a biotin tag (Sigma-Aldrich Corporation, Milwaukee, U.S.A)  which was used to attach it 
to avidin coated magnetic beads (Invitrogen Corporation, California, U.S.A). The interaction 
of avidin and biotin has been widely used and is a high affinity interaction (Grunwald 2008). 
The Watson Crick base pairing between bridge sequence and complement attaches the pool to 
beads.  These complexes were then exposed to the target. The random sequence regions that 
interacted with the target were expected to undergo a structural change (Nutiu and Li 2005). If 
the change in structure reduced the interaction between the bridge and complement sequence, 
the DNA was released from the beads. This DNA of interest was separated from the DNA still 
attached to the beads by pelleting the beads using a magnet. The supernatant contained the 
DNA of interest. This selection method has two selection pressures; first the DNA must bind 




Figure 6. Methods used for SELEX I) Method I: DNA pool is attached to beads, FDA is 
added, magnet is applied, and supernatant contains DNA of interest II) Method 
II: FDA is attached to beads, DNA or RNA pool is added, magnet is applied, 
supernatant discarded, and pellet contains DNA or RNA of interest. 
 The second method (method II, Figure 6b) attempted involved having FDA bound to 
beads and introducing DNA pool. In this method, FDA was bound to the avidin coated beads 
via a biotin linker. The DNA pool in this case does not require a bridge sequence. However, 
the DNA pool used did contain a bridge sequence flanked by random regions. The DNA that 
interacts with FDA was pulled into pellet along with beads using a magnet. The supernatant 
containing DNA that does not interact with DNA was then removed and discarded. The pellet 
was then dissolved in denaturing buffer. This prevents DNA from folding and interaction with 
FDA. When the beads were pelleted this time, the DNA of interest was in the supernatant. 
67 
 
 The DNA of interest was then amplified using PCR. The minimum number of PCR 
cycles required to produce detectable amounts of DNA was determined. This was done by 
taking running samples from different numbers of PCR cycles on an agarose gel with ethidum 
bromide stain. As selection rounds are repeated the amount of DNA in the pool that has 
affinity for the target should increase leading to a decrease in the number of PCR cycles 
required to obtain detectable amounts of DNA.  
 The selection using method I did not lead to any reduction in PCR cycles required to 
detect DNA by the eighth selection round. Using method II, the first selection round the PCR 
had thirty cycles and by the eighth selection round the PCR required twenty cycles (Figure D1, 
in Appendix).  
 In order to determine if sequences of DNA had converged, colony PCR was performed 
using the DNA pool from round eight.  Colony PCR was done using a kit purchased from 
Invitrogen (Invitrogen Corporation, California, U.S.A). The DNA sequences were inserted 
into a vector containing coding sequence for β-galactosidase α peptide regulated by the lac 
operon (Hu, Kornacker and Hochschild 2000, Vieira and Messing 1982). The vectors were 
then transformed into E. coli cells. The cells were plated on LB plates containing bromo-
chloro-indolyl-galactopyranoside (X-Gal) and isopropyl β-D-thiogalactoside (IPTG). IPTG 
triggers the expression of lac operon. Insertion of DNA into vector disrupts the sequence of β-
galactosidase α peptide. Colonies that have a vector with a DNA insert were not able to break 
down X-gal, due to disrupted β-galactosidase α peptide. These colonies appear white; colonies 
that appear blue have a vector with no DNA insert. β-galactosidase α peptide  breaks down X-
gal into 5-bromo-4-chloro-3-hydroxyindole, which breaks down into 5,5’-dibromo-4,4’-
dichloro-indigo, which gives cell blue color (Gabelsberger, Liebl and Schleifer 1993). Several 
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blue tinted colonies were observed and twelve individual white colonies were obtained. The 
DNA sequence insert from the white colonies were amplified using PCR. The sequences were 
then sent for sequencing (Operon, Alabama, U.S.A). 
 Figure 7A shows the alignment of twelve sequences obtained from colony PCR of the 
eighth selection round.  While the sequences did not appear to converge, some of the 
sequences are G rich. G rich sequences have a propensity to form G quadruplexes which have 
been shown to bind to a variety of targets (Haider, Neidle and Parkinson 2011). The twelve 
sequences were analyzed using an online G quadruplex predictor (QGRS Mapper). The 
prediction is based on an algorithm that examines the distance between G’s in a sequence 
(Kikin, D'Antonio and Bagga 2006). Three sequences (DNA_FDA_3, DNA_FDA_6, 
DNA_FDA_8) were identified that might have the propensity to form a G quadruplex (Figure 
D2 in Appendix). 
 The lack of convergence of sequences was in contrast to the sequences obtained from 
round seven of the RNA selection, using method II, conducted by Dr. Thorsten Dieckmann 
(see Figure 7B). Since the RNA selection looked more promising nine more rounds of 
selection were conducted by Jenna Collier, then attempts were made to characterize its 




Figure 7 Multiple sequence alignment using Clustal 2.1 A) Round 8 from DNA SELEX 
B) Round 7 from RNA SELEX. Color coded A:RED; C:BLUE; G:ORANGE; 
T:GREEN. Below the sequences is a graph of homology versus sequence 
position. 
RNA binding experiments  
 These experiments were performed with the assistance of Jenna Collier and Marie 
Claire Lacassin. The procedure is similar to method II used for selection seen in Figure 6b. 
The difference being that the supernatant that is discarded in the selection is collected and 
mixed with an indicator. The indicator in this context is a dye molecule that fluoresces upon 
binding RNA. The amount of fluorescence was detected and corresponds to the amount of 
RNA that does not bind to FDA.  
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  The first indicator used was SyberGreen II (Invitrogen Corporation, California, 
U.S.A). This indicator is commonly used in RNA gels in place of ethidium bromide. Results 
obtained using SyberGreen II were inconsistent leading to the use of RiboGreen (Invitrogen 
Corporation, California, U.S.A). RiboGreen is advertised for optimal determination of RNA 
concentration in solution versus SyberGreen which is optimized for gel use. However these 
results were inconsistent as well. The initial control used was RNA exposed to beads which 
had no FDA bound. A control with FDA bound to beads and no RNA revealed the source of 
inconsistency. It appeared that some of the FDA hydrolyzed to fluorescein and was in solution. 
Since both SyberGreen II and RiboGreen share emission maxima with fluorescein, the 
fluorescence measurement did not accurately represent binding. The next indicator tested, 
Cy5 (Invitrogen Corporation, California, U.S.A), was obtained since it has a different 
emission maxima (Figure 8). Unfortunately experiments with Cy5 showed interaction of Cy5 
with beads. Fluorescence measurements are summarized in Table D1 in Appendix. 
 
Figure 8. Emission (solid line) and Excitation spectra (dash lines) for fluorescein (red), 
SyberGreen II (blue), RiboGreen (black) and Cy5 (green). Created using 






Aptamer selection  
 Method I was identical to previous reported selection for a structure switching DNA 
aptamer targeted at adenosine triphosphate (Nutiu and Li 2005).  This method places two 
selection pressures; first the DNA must bind to target and second the binding of the target 
must trigger a structural change. The combination of both of these selection pressures may 
have been excessive to allow for selection for binding to FDA. 
 Method II had one selection pressure, which was binding to target. The removal of the 
selection pressure for structure switching improved the ability of DNA to survive selection 
rounds. The presence of possible G quadruples is interesting as these motifs are implicated in 
a variety of functions including translation initiation and mRNA stability. However, the 
presence of the bridge region could have limited the variety of structures that DNA could fold 
into. This explains why the RNA selection was able to converge in seven selection rounds. 
The RNA starting library did not contain a bridge sequence, which allowed for more 
sequences to be explored. 
RNA binding experiments 
 The observation that fluorescein was interfering with indicator dye signal emphasized 
the need for appropriate controls. A literature search revealed that Cy5 can under some 
circumstances interact with avidin (Gruber et al. 2000), which could explain the observed 
interaction with the beads. The beads are avidin coated and FDA is attached to avidin via a 
biotin linker. To avoid any complications that may arise from this potential interaction, an 




4. Conclusions and Future work 
 Our attempt to obtain a DNA aptamer for FDA will be repeated with a starting library 
similar to the one used for the RNA aptamer selection. The bridging region is ideal for 
selection of an aptamer with structure switching capability; however since structure switching 
isn’t the chief goal, this setup would not be necessary for our purposes. Removing selection 
pressure for structure switching should expand the number of sequences explored.  
 The binding properties of the RNA aptamer sequences will be further studied using 
radioactively labelled RNA. This method has been previously used for determining binding 
affinity of aptamers (Gopinath S. et al. 2006) and by Dr. Dieckmann in the RNA selection 
process to monitor increase in binding to beads. Briefly described, the process involves 
dephosphorylation of 5’ of RNA using calf intestinal alkaline phosphatase followed 
attachment of adenosine triphosphate [γ
32
P] to RNA using T4 polynucleotide kinase. This 
RNA is introduced to FDA bound beads, followed by ten washes to remove RNA that doesn’t 
bind; the RNA that stays bound is then measured using a scintillation counter.  
 RNA sequences with the highest affinity will then be shortened to determine the 
minimal binding sequence. At this point the DNA analog of the minimal sequence will be 
investigated for FDA binding based on the occurrence of DNA analog binding as mentioned 
previously. The sequences will then be tested for the presence of FDA hydrolysis by 
monitoring fluorescein fluorescence.  
 If no catalytic activity is detected a new selection will be conducted using a pool 
containing FDA binding sequences and selection pressure for hydrolysis will be applied. The 
application of selection pressure for activity utilizes a substrate that is linked to both column 
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and RNA pool sequences. RNA that modifies the substrate through cleavage is separated from 
the sequences that stay attached to the column and thus can be isolated for enrichment 
(Wilson and Szostak 1999). A similar approach can be used in the search for FDA 
hydrolyzing RNA. 
5. Materials and Methods  
DNA selection 
 The random DNA library (approximately 10
15
 molecules) was obtained courtesy of Dr. 






GCGGAGCGTGGCAGG 3’, along with the primer 1: 5’ACGATGCGGGTGCCA 
AGCTTA3’(A is  ribo-terminated A in primer 3), primer 2: 5’CCTGCCACGCTCGCAAG3’ 
and BiotinDNA: BGGTCAGCATTCTTGACGATGATGATGATGAT3’ (B biotin attached) 
which is used in method II. As mentioned the DNA selection was preformed based on a 
previously described method (Nutiu and Li 2005). 
For method I, 2 nmol of the DNA library, 10 nmol of BDNA and 2.5 nmol each of 
primer 1 and primer 2 were incubated in wash and binding (WB) buffer (100 mM NaCl, 500 
mM KCl, 10 mM MgCl2, 100 mM phosphate buffer pH 7) at 277 K overnight. This mixture 
was then incubated with 200 μL of washed avidin-coated magnetic beads (Invitrogen 
Corporation, California, U.S.A) for 30 min at room temperature. The beads were washed with 
ten volumes of WB buffer. The beads were then pulled to bottom using a magnet and the 
supernatant was then removed. The beads were then washed ten more times with 200 µl of 
WB buffer. Then 0.1 mM FDA was added to beads and allowed to equilibrate for 30 min. The 
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beads were then pulled to bottom using a magnet and the supernatant containing DNA of 
interest was collected.  
For method II, 2 nmol of the DNA library and 2.5 nmol each of primer 1 and primer 2 
were incubated in wash and binding (WB) buffer (100 mM NaCl, 500 mM KCl, 10 mM 
MgCl2, 100 mM phosphate buffer pH 7) at 277 K overnight. This mixture was then incubated 
with 200 μL of washed avidin-coated magnetic beads (Invitrogen Corporation, California, 
U.S.A) for 30 min at room temperature. The beads were washed with ten volumes of WB 
buffer. The beads were then pulled to bottom using a magnet and the supernatant was then 
removed. The beads were then washed ten more times with 200 µl of WB buffer. Then 200 µl 
of 10 mM KOH was added to beads. This solution was allowed to incubate for 10 mins at 
room temperature. The beads were then pulled to bottom using a magnet and the supernatant 
containing DNA of interest was removed. 
The solution containing DNA of interest was amplified using ribo-terminated primer 3 
and primer 2. The number of cycles required was determined by running 30 cycles and 
collecting samples at 10, 15, 20 and 30 cycles. These were run on an agarose gel with 
ethidium bromide stain. After determining the number of cycles required a 300 µl PCR was 
run. After phenol chloroform extraction and ethanol precipitation the DNA was treated with 
90 µl of 0.25 M NaOH at 363 K for 10 min. Followed by neutralization by addition of 10 µl 
of 3 M sodium acetate pH 5.5. The DNA was then ethanol precipitated and run on a PAGE 
gel. For the next rounds, the purified DNA from the previous round was mixed with primer 1, 
primer 2 and BDNA. This mixture was denatured at 363 K for 5 mins and annealed at room 
temperature for 30 minutes in WB buffer before addition of 200 μL washed avidin-coated 




Colony PCR was done using a kit from Invitrogen (Invitrogen Corporation, California, 
U.S.A) and following their procedure. Briefly descirbed, DNA from the round to be 
sequenced was amplified using PCR with an addition elongation step. This step adds 
adenosine runs to the 3’ end of the sequence. Then the DNA was cloned into a vector and 
vector was transformed into cells. The cells were then plated on lysogeny broth (LB) plates 
with ampicillin and X-gal. In 12 hours white colonies were visible and some with a blue tint 
(Figure D3, Appendix). Blue colonies indicated a lack of insertion of vector and were not 
picked. White colonies are picked with pipette tip and mixed with PCR solution. This PCR 
includes an extra heating step to denature the cells and release DNA. After PCR the DNA is 
extracted using the phenol chloroform method and ethanol precipitated and then sent for 
sequencing. Our sequences were sent to Operon (Operon, Alabama, U.S.A). PCR protocols 
for elongation and colony preparation are in Table D2 in Appendix. 
Binding test 
 RNA concentration was determined using a NanoDrop 2000 (Thermo Fisher Scientific 
Company, Ontario, Canada) by measuring absorbance at 260 nm. The RNA was then diluted 
to a 1 uM solution in WB buffer. 40 µl of RNA 1 uM solution was then added to 50 µl of 
washed avidin-coated magnetic beads. The solution was allowed to incubate for 10 min at 
room temperature. The beads were then pulled to bottom using a magnet and the supernatant 
was collected. This solution was mixed with an equal volume of indicator solution and 
fluorescence was measured using NanoDrop 3300 (Thermo Fisher Scientific Company, 
Ontario, Canada). SyberGreen II indicator solution was made by adding 1 ul from 
concentrated stock (Invitrogen Corporation, California, U.S.A) to 199 µl WB buffer. 
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RiboGreen indicator solution was made by adding 1 ul from concentrated stock (Invitrogen 
Corporation, California, U.S.A) to 199 µl WB buffer. Cy5 indicator solution was made by 
adding 5 ul from concentrated stock (Invitrogen Corporation, California, U.S.A) to 195 µl 
WB buffer.  
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 This chapter covers two projects that have not fully achieved their end goal.  The first 
project involves the design of alternate MGA DNA templates in order to maximize uniform 
length products from T7 polymerase transcription. The motivation for this project was to 
ensure that the investigation of MGA was not compromised by presence of MGA with extra 
nucleotides appended to 3’ tail. The attempt involved using enzymes, ribozymes and 
DNAzymes, both of which are discussed below. The second project involves the design of a 
new ligand for MGA. The intent was to provide MGA with a substrate that it would be able to 
catalyze into a product faster than background.  The notion that RNA aptamers can have 
catalytic activity based on ligand provided without the need for selection pressure for catalytic 
activity during SELEX is discussed below.  
Ribozymes 
 
 Ribozymes are catalytic RNA sequences. The two ribozymes used in this work are the 
hammerhead and hepatitis delta virus ribozymes. Hammerhead (HH) ribozyme is found in 
plant viruses, this naturally occurring ribozyme cleaves phosphodiester bonds. This cleavage 
reaction is important for viroid replication (Prody et al. 1986, Pley, Flaherty and McKay 
1994, Branch and Robertson 1984). The minimal catalytic sequence of the hammerhead 
ribozyme was determined and contains three stem regions and a catalytic core (Figure 1) 
(Scott, Finch and Klug 1995). Three nucleotides have been identified that play key roles in 
cleavage. G5 is responsible for positioning the substrate while G12 and G8 have been 
implicated in an acid-base catalysis reaction (Peracchi et al. 1998, Martick et al. 2008, Scott 
2007). The full length ribozyme has higher activity achieved by optimization of the 
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positioning of these three nucleotides by tertiary interactions of stems (Martick and Scott 
2006). Interestingly this ribozyme has been identified within fungi, archea and bacteria 
(Perreault et al. 2011).   
 The second ribozyme also plays an important role in viral replication and is found in 
the hepatitis delta virus (HDV) (Kuo et al. 1988).  The HDV ribozyme contains five helices 
which are connected by a double psuedoknot (Figure 2) and is responsible for a cleavage 
reaction similar to HH ribozyme (FerreDamare, Zhou and Doudna 1998).  In this case the 
ribozyme works with a divalent cation to achieve cleavage reaction (Shih and Been 2002).   
The divalent metal acts as a general acid along with C75 to achieve acid-base catalysis (Chen 
et al. 2010). This ribozyme has also been shown to induce conformational changes in its RNA 
substrate (Ke et al. 2004), a trait shared by MGA and other aptamers discussed in Chapter 1. 
 
Figure 1.  Structure of HH ribozyme, A) Crystal structure obtained using 2’-O-methyl 
cytosine to prevent cleavage (PDB 1MME). B) Secondary structure schematic. 
In both A) and B); Purple represents nucleotide where cleavage occurs (any 
nucleotide but G); Green represents the conserved sequences; Red represents 
other nucleotides (Scott, Finch and Klug 1995). Figure was generated using 




 Both HH and HDV ribozymes have found application in molecular biology to ensure 
homogeneous in vitro T7 RNA polymerase transcription. Homogeneous sequences are desired 
since additional nucleotides could change the secondary structure of transcript. T7 RNA 
polymerase is prone to adding nucleotides on the 3’ end of transcript. By adding a self-
cleaving ribozyme at the end of the transcript, the homogeneity of the desired RNA can be 
obtained by removal of the ribozyme (Shields et al. 1999, Chowrira, Pavco and Mcswiggen 
1994, Blight and Rice 1997). 
 
Figure 2.  Structure of HDV ribozyme A) Crystal structure obtained using 2’-OH 
nucleophile was changed to a 2’-H.  B) Secondary structure schematic. In both 
A) and B); Purple represents nucleotide where cleavage occurs; Green 





 Another method for obtaining a homogenous transcript is the use of a DNA enzyme 
that was selected for RNA cleavage. The enzyme consists of a 15 nucleotide core flanked by 
substrate complementary sequences (Figure 3) (Santoro and Joyce 1997). The activity of the 
DNAzyme has been shown to be dependent on the presence of Mg
2+
. This ion is implicated in 
the deprotonation of the 2’ OH, a role similar to the one it plays in the HDV ribozyme 
(Santoro and Joyce 1998). This enzyme has been used to target hepatitis C virus genomic 
RNA with promising results (Kumar et al. 2009).  
 
Figure 3. Secondary structure of DNAzyme catalytic motif. DNAzyme – Black; Target 
RNA – Green, R = A or G; Y = U or C. 
Catalytic aptamers 
 The DNAzyme isn’t the only molecule that has been selected for catalytic activity. 
SELEX has been modified to select catalytic RNA. Reactions that RNA sequences have been 
selected to catalyze include an aldol reaction (Fusz et al. 2005), aminoacylation (Illangasekare 
et al. 1995), amide synthesis (Wiegand, Janssen and Eaton 1997), urea synthesis (Nieuwlandt 
et al. 2003), Diels Alder (Agresti et al. 2005), Michael additions (Sengle et al. 2001), 
alkylation (Wecker, Smith and Gold 1996), peroxidase (Liu et al. 2009), metalation (Kawazoe 
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et al. 2001) and cofactor dependent redox reaction (Tsukiji, Pattnaik and Suga 2003). 
Interestingly, the RNA with peroxidase activity was selected for binding to hemin (Liu et al. 
2009) and the metalation activity was seen in a RNA selected for binding to N-
methylmesoporphyrin (Kawazoe et al. 2001). These aptamers were selected for binding and 
had inherent catalytic activity. This is also seen in MGA which was selected for binding MG. 
MG has a positive charge which resulted in a selection pressure for an electronegative pocket. 
This was harnessed by catalysis of a reaction with a positive transition state and MGA has 
been shown to catalyze the hydrolysis of acetoxy derivative of MG (MGOAc) (Figure 4) at 
1000-fold over background of the same reaction pathway (Brackett and Dieckmann 2006).   
 
 
Figure 4.  MGOAc hydrolysis to hydroxy MG and acetate. 
 
2. Results and Discussion 
 
MGA template modification 
 
 The first attempt to obtain homogenous RNA was to append HDV to the 3' end of the 
MGA. A second template was designed with HH to the 5’ and 3’ ends of MGA. Both 
template are shown in Figure 5. HDV and HH modified clones were designed and developed 
by Dr. Elaine Collins (San Jose State University, California, USA).  The template were 
designed using Assembly PCR Oligo Maker (Rydzanicz, R. et al. 2005) 
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(http://startrek.ccs.yorku.ca/Epjohnson/AssemblyPCRoligomaker.html ).The modified DNA 
templates were obtained from Sigma-Aldrich (Sigma-Aldrich, Missouri, U.S.A) and 
following PCR was then inserted into a vector . The vector was then transfected into cells. 
This allowed for large scale preparation of the templates, since large quantities of the cells 
could be grown. The DNA was then purified using a DNA purification kit (Qiagen). Then the 
DNA was excised from vector using restriction enzymes, and after purification the DNA was 
used in transcription reactions. 
 





HDV MGA template 
CCATTATGCTGAGTGATATCCCCTCGCTGACCGCTCTCGGTCCATTGCTTAGAGGGGCCAGCCGACGTCTGGGTCGGAGGAGC
GCCCGGGCTGGACCCGTAGAAGCCTACCGCTTACCCAGT   
 
Figure 5. Ribozyme MGA templates: Highlighted in yellow is T7 promoter;  in Green is 
MGA DNA; in Red and Purple is ribozyme; in Purple are residues important 
for catalysis 
 After the templates were purified, the RNA was transcribed as previously described. 
The RNA was then purified and dissolved in catalysis buffer (50 mM Tris pH 7.0, 100 mM 
NaCl, 10 mM MgCl2). The concentration of magnesium was increased but did not result in 
more cleavage consistent with previous report by Chowrira et al. (Chowrira et al. 1994). HH 
ribozyme was not as active as HDV, since a large amount of uncleaved RNA was found after 
twelve hours. (Figure E1 in Appendix).  
 In an attempt to obtain cleaved homogenous RNA, without the addition of significant 
length, a template was designed that could be cleaved by the DNAzyme (Figure 6). The 
change in length of the sequence is significantly smaller than HDV or HH MGA templates. 
The enzyme did cleave some of the product, a significant portion was left uncleaved, and 
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attempts were made to vary temperature and magnesium concentration with no significant 




Figure 6.  DNAzyme MGA template: Highlighted in yellow is T7 promoter; Green is 
MGA DNA, Red and Purple is DNAzyme MGA DNA; Purple is changes 
made to accommodate interaction with DNAzyme; Blue is DNAzyme. In 
Green font is MGA shown interacting with DNAzyme (Red font depicts the 
target identifying sequences, Black font shows the catalytic core). 
 The secondary structures of the three RNAs discussed are depicted in Figure 7. These 
structures reveal a possible explanation for the low cleavage rate. For the HDV MGA the 
lowest energy structure predicted does not form the required base pair interaction with 
nucleotides neighbouring the cleavage site. In the case of the HH MGA the trans-ribozyme is 
predicted to fold optimally, while the cis-ribozyme does not fold to ensure that cleavage site 
in the appropriate position. Also, the reduction in yield is expected because of the additional 
length of transcript; a significant portion of the RNA transcribed was being cleaved off to 
obtained homogenous samples. The DNAzyme MGA is also predicted not to fold as intended 
when initially designed. This is apparent because of extra base pairs formed in catalytic core 




Figure 7. Secondary structure predictions with MGA highlighted in Green and sequences 
important for catalysis in Red. A) HH ribozyme MGA RNA B) HDV ribozyme 
MGA RNA C) DNAzyme MGA RNA and DNAzyme (separated by &). A) 
and B) Generated using mfold. C) Generated using Vienna RNAcofold. 
 
 Another method attempted involved addition of a 2’-O methyl group to 3’ of MGA 
template DNA, this has previously been reported to reduce n+1 transcription products (Kao, 
Zheng and Rudisser 1999). Unfortunately this produced an additional band which was 
detected during the gel purification step (Figure E3 in Appendix). This phenomenon was not 
investigated further.  
 To determine if there was a significant presence of n+1 RNA mass spectrometry 
experiments were conducted.  The analysis of mass spectrometry data revealed two peaks 
with the first peak at 12578 mass identified as n and the second peak at 12905 mass identified 
as n+1 (Figure 8A). Using a molecular weight calculator 
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(http://www.currentprotocols.com/tools/dnarnaprotein-molecular-weight-calculator), the mass 
of n is predicted at 12521 Da and n+1 at 12850 Da. A sample containing MGA mixed with 
MG was then run. This spectrum showed presence of n+1 binding dyes (Figure E4 in 
Appendix).  Also, a secondary fold prediction of MGA with an extra nucleotide did not result 
in a significant change in structure (Figure E5 in Appendix), and the use of double stranded 
template DNA reduced the amount of n+1 significantly (Figure 8B). Based on these findings, 
n+1 MGA was deemed to be similar enough to MGA that further attempts to isolate 
homogenous MGA were deprioritized. 
 
 
Figure 8. Mass spectra of A) MGA from transcription with a single stranded template B) 
MGA from transcription with double stranded template 
Changes in Ligand 
 MGA has previously been shown to have catalytic activity (Brackett and Dieckmann 
2006) when provided with an ester derivative of MG. In order to investigate the catalytic 




the ligand for MGA was met with limited success. MGA binds to MGNCS as seen by a shift 
in visible spectra (Figure 9).  However no reaction was observed when this complex was 
exposed to lysine (Figure E7 in Appendix). This reaction was attempted since fluorescein 
isothiocyanate is commonly used to covalently attach fluorescein to peptides (Johnson, 
Yguerabide and Taylor 1984, Breier and Ziegelhoffer 2000) and MGNCS has been used for 
the same application (Golding et al. 1998). The covalent bond found is a thiourea bond by 
reaction of the side chain amine of lysine and isothiocyanate group (Breier and Ziegelhoffer 
2000). While the electronegative pocket would stabilize positive transitions states it maybe 
that the pocket does not allow for optimal interaction of the lysine with the ligand. The 
hydrolysis reaction that MGA catalyzes requires that water be able to enter pocket. Lysine is a 




Figure 9. A) Chemical structure of MGNCS B) Visible Spectra of MGNCS (Red) and 
MGNCS mixed with excess of MGA (Purple). 
 Since formation of a bond would meet with the same difficulty as thiourea bond 
formation, that is the entry of the second substrate. An attempt was made to synthesize 
MGCOOCF3 (Figure 10A), in order to observe if MGA could catalyze another hydrolysis 





which due to the negative charge would be ejected from MGA pocket. However this molecule 
was hydrolyzed in water at a fast rate. This was determined by mixing MGCOOCF3 in both 
water and methanol solutions, each of the solutions were then analyzed by mass spectrometry 
(Figure E8 in Appendix). In water the sample spectra contained a 375 peak, which suggests 
MGCOO (Figure 10B). In methanol the sample spectra contained a 387 peak, which suggests 
MGCOOCH3 (Figure 10C). In order to reduce the rate of hydrolysis an attempt was made to 
synthesize MGCOphenol (Figure 10D), however the product proved to be insoluble in water.  
 Since attempts to design a ligand that would undergo a reaction other than the 
previously reported ester hydrolysis that MGA could catalyze were not successful, the next 
approach involved placing the same ester group deeper within the pocket. Michlers ketone 
(Figure 10E) was purchased in order to synthesize a molecule with an ester group at central 
carbon, based on a report of it its reactivity with acetyl chloride (Gilman and Heck 1930). 




Figure 10. Chemical structures of MG derivatives A) MGCOOCF3 B) MGCOO C) 




3. Conclusions and Future Work 
 
 While the strategy of using ribozymes to ensure homogenous transcripts is an elegant 
one, it may not be cost effective for a short aptamer. It appears that the gel purification 
method used does leave some n+1 sequence; however, in the case reported here these 
sequences appear to be functional. It is worthwhile to use the HDV template to generate a 
large amount of homogenous RNA and conduct ITC experiments to compare our current ITC 
data. The synthesis of new MGA derivatives should be attempted beginning with further 
experiments with Michlers ketone, more specifically a synthesis reaction  involving Michlers 
ketone and benzyl chloride that was previously reported (Gilman and Heck 1930). 
4. Thesis Conclusions 
 The goal of this work has been to show the capacity of RNA for function. Our work 
with MGA has shown that varying the salt concentration was able to change the preference of 
ligand. Secondly we have shown that binding of MGA can be influenced by a pre-bound 
ligand. These characteristics suggest that RNA is capable of maintaining the capacity for 
functions not selected for. This would have been an excellent ability in a prebiotic world, 
since one pool of RNA could develop multiple functions. These characteristics should be kept 
in mind while developing applications for MGA, since the solution conditions effects its 
binding ability. Our work with MGA also reaffirms the need to preform characterisations 
under different solution conditions. The NMR experiments were conducted in the absence of 
Mg
2+
 to avoid issues with degradation.  
5. Materials and Methods 
HH and HDV MGA DNA template preparation 
 
 In order to prepare the necessary templates Sure2 competent cells containing pUC18 
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plasmid, designed by Dr. Elaine Collins, were grown on lysogeny (LB) plates containing 
ampicillin (100 µg/mL). A single isolated colony from the plate was used to inoculate 100 mL 
of LB broth. Culture was incubated at 37
o
C for 12 h. The cells were then spun down at 4000 g 
for 30 min. The plasmid from the pellet was purified using Qiagen Plasmid Plus Purification 
Kit (Qiagen, Toronto, Canada). The protocol provided by Qiagen (Qiagen, Toronto, Canada) 
was followed to obtain the plasmid in water. The plasmid was then linearized with Bam H1 
(Fermentas, Burlington, Canada). Completion of digestion was observed by running a 1% 
agarose gel containing ethidium bromide. The reaction mixture was then purified using 
Qiagen PCR purification kit (Qiagen, Toronto, Canada) and concentration of purified DNA 
was determined using absorbance at 260 nm. Transcription reaction was performed using the 
protocol described in Chapter 2, the same protocol was used for double stranded and single 
stranded MGA templates. 
Ribozyme Cleavage Reaction 
 
 RNA from transcription was dissolved in cleavage buffer I (50 mM Tris HCl, pH 7.5, 
100 mM NaCl and 10 mM MgCl2). This mixture incubated at 90
o
C for 5 min then at 4
o
C for 5 
min, this hot and cold cycle was repeated three times. The solution was then allowed to react 
at 37
o
C for 4 hrs. The resulting solution was then run of a 12% polyacrylamide gel and 
purified on columns according to the protocol described in Chapter 2. 
DNAzyme Cleavage Reaction 
 RNA from transcription using DNAzyme MGA template was dissolved in cleavage 
buffer II (50 mM Tris HCl, pH 7.5, 150 mM NaCl, and 10 mM MgCl2. The concentration of 
RNA was determined using absorbance at 260 nm. DNAzyme was added to RNA for a final 
molar ratio of 1:1. This mixture incubated at 90
o
C for 5 min then at 4
o
C for 5 min. The 
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solution was then allowed to react at 37
o
C for 4 hrs. The resulting solution was then run of a 
12% polyacrylamide gel and purified on columns according to protocol described in Chapter 
2. 
RNA Mass Spectrometry Procedure 
 RNA samples for MS were ethanol precipitated using two times the volume of ethanol 
and one tenth the volume of 3 M ammonium acetate. The procedure used for mass 
spectrometry analysis was adapted from a procedure reported by Gooding K.B, et al. 
(Gooding et al. 2004, Greig and Robinson 2000). Samples were dissolved in 50% 
isopropanol, 25% water and 25% acetonitrile. Then they were run on a Micromass Q-TOF 
Ultima Global (Waters Cooperation, Masssachusetts, U.S.A) with negative electrospray 
ionization.  The resulting spectra were processed using software provided by Waters 






 MGNCS was purchased from Invitrogen, Ontario, Canada. The dye was weighed and 
dissolved in acetonitrile for storage as a 100 µM stock solution. A solution  with final 
concentration of 5 µM MGNCS  and 32 µM MGA was prepared in 50 mM NaCl, 25 mM 
phosphate buffer at pH 5, lysine was added to a final solution of 10 µM. The background 
reaction was observed with same concentration of MGNCS and buffer in the absence of 
MGA. 
Lysine MG product was synthesized by mixing MGNCS with excess lysine in a pH 9 
phosphate buffer for 60 min, procedure was based on a previous report (Johnson, Yguerabide 
and Taylor 1984). The visible spectra of lysine MG had a maximum at 590 nm (Figure E6 in 
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Appendix), there was no change in presence of MGA. The catalysis reaction was measured by 




 First, MGCOOH was synthesized according to published report(Cho et al. 2003). The 
synthesis involved stirring dimethylaniline and 4-carboxy benzaldehyde in concentrated HCl 
for 12 hrs under nitrogen. This was followed by neutralization with NaOH and extraction into 
ether. The solution was then dried with sodium sulfate. The leuco-base was purified by flash 
chromatography using 9:1 hexane and ethyl acetate. The leuco-base was then dissolved in 
chloroform with an excess of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone. The dye was then 
purified by flash chromatography using 5:1 chloroform and methanol. Positive ESI mass 
spectrometry was used to confirm the formation of the desired product. MGCOOH was then 
reacted with 2,2,2-Trifluoroethanol in dichloromethane, this was done following the protocol 
reported by Srinivas K., et al. (Srinivas, Mahender and Das 2003). MGCOphenol synthesis 




 Michlers ketone was purchased from Sigma-Aldrich, Missouri, U.S.A. The alcohol 
was synthesized following procedure report by Dumur F., et al.(Dumur et al. 2008). Briefly, 
this involved boiling in THF in the presence of sodium borohydride. The alcohol was then 
reacted with excess acetyl chloride. Positive ESI mass spectrometry was used to confirm the 
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Table A1: RNA sequences for various targets with structural features identified to showcase the 




Neomycin B GGACUGGGCGAGAAGUUUAGUCC 













base pairing with Y74 




HIV Rev GGUGUCUUGGAGUGCUGAUCGGACACC 
UAU triple, hydrogen 
bonding with Arg 35 and 
Arg 39, elongated form 
HIV Rev GGCUGGACUCGUACUUCGGUACUGGAGAAACAGCC 
UAU triple, stacking of 
Trp45, helical form 
HIV TAR GGCUGGUCCCAGACGACC kissing complex 
HIV DIS CUUGCUGAAGUGCACACGCAAG kissing complex 
HIV Tat GGGAGCUUGAUCCCGGAAACGGUCGAUCGCUCCC two adjacent UAU triples 
MS2 coat 
protein CCGGAGGUCACCACGGG 
A10 makes three 
hydrogen bonds with 
target 
RNA 
polymerase II ACAGCACUGAUUGCGGUCGAGGUAGCUUGAUGG A-form helix 
Bovine prp GGAGGAGGAGGA GGGG tetraplane 
Human IgG GGAGGUGCUCCGAAAGGAACUCCA G7 stacking with Tyr373 
NF-kb factor  GAUACUUGAAACUGUAAGGUUGGCGUAUC resembles B-form DNA 
Mammalian 
factor 4A  
GGAGAUCGCACUCCACAUGUGAGUGAGGCCGAAACAUAGAUUCG
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Figure B1. Binding curves from equilibrium dialysis experiments preformed at 100mM 
phosphate buffer, 50mM NaCl, pH6.0. The binding curves were fit using Origin using 
the equation   y  = (Bmax * x) / (Kd + x). 
 
Figure B2. Binding curves from Nanodrop fluorescence experiments preformed at 50mM 
phosphate buffer, 150mM NaCl, pH6.7. The binding curves were fit using Origin using 








Figure B3. Right: Typical ITC raw data showing heat generated over time as dye is injected into 
cell containing MGA RNA. Left: Integrated data fitted using Origin to a single binding 
site model which provides Kd, ΔH, ΔS values. Experiments were preformed at 10mM 
phosphate buffer with varying salt concentrations (1mM, 150mM, 1M) , pH 6.7. 
 
Figure B4. Plot of log Ka versus log [Na+] for MG, TMR and PY binding to MGA. Data points were 
fit using linear regression (Excel) to generate lines and equations. Linear regression 
fits of shown as solid lines (_____) MG data (y = 0.1306x + 6.5273, R2 = 0.7426), TMR 




Figure C1 Typical ITC raw data showing heat generated over time. Experiments were 
performed at 10 mM phosphate buffer with either 150 mM NaCl or 10 mM MgCl2, 
pH 6.7. 
 
Figure C2 Plot of total energy versus simulation time showing plateauing of rate of change. 





Table C1.  Comparing multiple injection and single injection values obtained from ITC at 25oC in  






Figure D1. DNA presence after n cycles of PCR after selection Round 1 lane 1: 0 cycles, lane 2: 
10 cycles, lane 3: 20 cycles, lane 4: 30 cycles. DNA presence after n cycles of PCR 
after selection Round 8 lane 5: 0 cycles, lane 6: 10 cycles, lane 7: 20 cycles. Gel 












Figure D2. Predicted quadruplex forming unit highlight and G involved underlined, identified 
using QGRS mapper.  
Table D1. Fluorescent measurement assay with Cy5 showing RNA interaction with avidin 




Ligand on beads Indicator Dye 
Before application on beads 880.3 n/a 665 White FDA Cy5 
After pull down  404.4 54 665 White FDA Cy5 
Before application on beads 804.1 n/a 665 White None Cy5 
After pull down  419.1 48 665 White None Cy5 
 
 
Table D2. PCR Protocols   
Protocol  
Selection Round Step 1: 95
o
C 10 min 
Step 2: 94
o
C 45 sec 
Step 3: 50
o
C 1 min 25 sec 
Step 4: 72
o
C 1 min 25 sec 




Elongation PCR Step 1: 95
o
C 10 min 
Step 2: 94
o
C 45 sec 
Step 3: 50
o
C 1 min 25 sec 
Step 4: 72
o
C 1 min 25 sec 
Step 2 to 4 repeated n times, n = #cycles 
Step 5: 72
o




Colony PCR Step 1: 94
o
C 10 min 
Step 2: 94
o
C 3 min 
Step 3: 45
o
C 1 min 
Step 4: 72
o
C 2 min 
Step 2 to 4 repeated 3 times 
Step 5: 94
o
C 45 sec 
Step 6: 50
o
C 1 min 25 sec 
Step 7: 72
o
C 1 min 55 sec 








Figure D3. LB plate with blue and white colonies. Blue colonies stand out more in the 
background of the lb plate. White colonies contain plasmid with insert of interest. 





Figure E1. Gel showing Hammerhead MGA lack of cleavage and HDV MGA cleavage. Lane 1 is 
HH MGA which hasn’t been heated. Lane 3 is HDV MGA which hasn’t been heated. 
Lanes 2 and 4 are HH MGA and HDV MGA respectively, in cleavage buffer I (50 mM 
Tris HCl, pH 7.5, 100 mM NaCl and 10 mM MgCl2). These mixtures (lane 2 and 4) 
were incubated at 90oC for 5 min then at 4oC for 5 min, this hot and cold cycle was 
repeated three times. The solution was then allowed to react at 37oC for 12 hrs. Lane 
5 is MGA that was transcriped using MGA template. Gel stained with Syber Green II 
RNA stain. 
 
Figure E2. Gel showing DNAzyme cleavage showing increase in temperature and magnesium 
concentration do not increase cleavage. DNAZyme MGA  loaded  in lanes were in 50 









and lane 5 had 50 mM MgCl2.  DNAZyme MGA mixture in lanes 2, 4 and 5 incubated 
at 90oC for 5 min then at 4oC for 5 min. The solution was then allowed to react at 
37oC for 4 hrs. DNAzme MGA mixture in lane 1 was incubated at 90oC for 5 min then 
at 4oC for 5 min, this was repeated three times.  Then the solution was allowed to 
react at 42oC  for 8 hrs. DNAzyme MGA mixture in lane 3 was  not heated. Gel was 
stained with Syber Green II RNA stain. 
  
 
Figure E3. Lane on left is RNA transcribed using 2’ O-methyl template; Lane on right is RNA 
transcribed with regular template. In lane on left clearly observable are two equally 





Figure E4. Mass spectra showing dye bound to n (12943 mass) and n+1 (13288 mass) MG 
bound to MGA. 
 
Figure E5. Secondary structure prediction using Mfold A) MGA B) MGA n+1. Showing identical 
secondary structure for n and n+1. 
 
Figure E6. Visible Spectrum of reaction product from MGNCS and lysine reaction after 60 min, 




Figure E7. Monitoring reaction of MGNCS and lysine in the presence of MGA (◊) and in the 
absence of MGA (□). Both reactions are in 50 mM NaCl, 25 mM phosphate buffer, pH 
5.0 and room temperature. The appears to be no increase in rate due to presence of 
MGA seen by the nearly identically slopes. 
 
Figure E8. Mass spectra of reaction product of MGCOOCF3 mixed with A) water with peak at 








Figure D9. Mass spectra of reaction product of Michlers ketone (268 m/z) and acetyl chloride, 
expected ester product would have mass of approximately 312 m/z. 
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